{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:50:35Z","timestamp":1794412235468,"version":"4.9.0"},"reference-count":547,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02851-w","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:01:26Z","timestamp":1785888086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets"],"prefix":"10.1038","volume":"11","author":[{"given":"Yufeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-9921","authenticated-orcid":false,"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3699-2630","authenticated-orcid":false,"given":"Yi-Zhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4503-148X","authenticated-orcid":false,"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2851_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41577-025-01132-x","volume":"25","author":"G Hajishengallis","year":"2025","unstructured":"Hajishengallis, G., Netea, M. G. & Chavakis, T. Trained immunity in chronic inflammatory diseases and cancer. Nat. Rev. Immunol.25, 497\u2013514 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","volume":"19","author":"DS Pisetsky","year":"2023","unstructured":"Pisetsky, D. S. Pathogenesis of autoimmune disease. Nat. Rev. Nephrol.19, 509\u2013524 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"2851_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira, G. & Wu, C. J. Dynamics and specificities of T cells in cancer immunotherapy. Nat. Rev. Cancer23, 295\u2013316 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","volume":"25","author":"M Roerden","year":"2025","unstructured":"Roerden, M. & Spranger, S. Cancer immune evasion, immunoediting and intratumour heterogeneity. Nat. Rev. Immunol.25, 353\u2013369 (2025).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41584-022-00904-2","volume":"19","author":"JJ Miner","year":"2023","unstructured":"Miner, J. J. & Fitzgerald, K. A. A path towards personalized medicine for autoinflammatory and related diseases. Nat. Rev. Rheumatol.19, 182\u2013189 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2851_CR6","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad, G., Helmink, B. A., Sharma, P. & Wargo, J. A. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell184, 5309\u20135337 (2021).","journal-title":"Cell"},{"key":"2851_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-022-00604-y","volume":"19","author":"EJ Villablanca","year":"2022","unstructured":"Villablanca, E. J., Selin, K. & Hedin, C. R. H. Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression? Nat. Rev. Gastroenterol. Hepatol.19, 493\u2013507 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2851_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41584-024-01169-7","volume":"20","author":"V Konzett","year":"2024","unstructured":"Konzett, V. & Aletaha, D. Management strategies in rheumatoid arthritis. Nat. Rev. Rheumatol.20, 760\u2013769 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2851_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41577-023-00965-8","volume":"24","author":"P Cruz de Casas","year":"2024","unstructured":"Cruz de Casas, P., Kn\u00f6pper, K., Dey Sarkar, R. & Kastenm\u00fcller, W. Same yet different\u2014how lymph node heterogeneity affects immune responses. Nat. Rev. Immunol.24, 358\u2013374 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","volume":"371","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore, G. D. et al. The microbiome and human cancer. Science371, eabc4552 (2021).","journal-title":"Science"},{"key":"2851_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41577-024-00998-7","volume":"24","author":"JW Swann","year":"2024","unstructured":"Swann, J. W., Olson, O. C. & Passegu\u00e9, E. Made to order: emergency myelopoiesis and demand-adapted innate immune cell production. Nat. Rev. Immunol.24, 596\u2013613 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel, T. R., Lill, J. K. & Altenburger, L. M. How chemokines organize the tumour microenvironment. Nat. Rev. Cancer24, 28\u201350 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR13","doi-asserted-by":"crossref","unstructured":"Wu, Z., Chen, X., Han, F., & Leeansyah, E. MAIT cell homing in intestinal homeostasis and inflammation. Sci. Adv. 11, eadu4172 (2025).","DOI":"10.1126\/sciadv.adu4172"},{"key":"2851_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2018.11.035","volume":"176","author":"OL Rojas","year":"2019","unstructured":"Rojas, O. L. et al. Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10. Cell176, 610\u2013624.e18 (2019).","journal-title":"Cell"},{"key":"2851_CR15","doi-asserted-by":"crossref","unstructured":"Liu, J., Zhang, X., Cheng, Y. & Cao, X. Dendritic cell migration in inflammation and immunity. Cell. Mol. Immunol. 18, 2461\u20132471 (2021).","DOI":"10.1038\/s41423-021-00726-4"},{"key":"2851_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cytogfr.2020.12.003","volume":"59","author":"X Yao","year":"2021","unstructured":"Yao, X. & Matosevic, S. Chemokine networks modulating natural killer cell trafficking to solid tumors. Cytokine Growth Factor Rev.59, 36\u201345 (2021).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2851_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.270","volume":"4","author":"X Lin","year":"2025","unstructured":"Lin, X. et al. Gut-X axis. iMeta4, e270 (2025).","journal-title":"iMeta"},{"key":"2851_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15831-7","volume":"11","author":"N Tajik","year":"2020","unstructured":"Tajik, N. et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat. Commun.11, 1995 (2020).","journal-title":"Nat. Commun."},{"key":"2851_CR19","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.cell.2021.11.018","volume":"184","author":"A Schnell","year":"2021","unstructured":"Schnell, A. et al. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity. Cell184, 6281\u20136298 (2021).","journal-title":"Cell"},{"key":"2851_CR20","doi-asserted-by":"publisher","first-page":"114181","DOI":"10.1016\/j.addr.2022.114181","volume":"184","author":"K Ronaldson-Bouchard","year":"2022","unstructured":"Ronaldson-Bouchard, K. et al. Engineering complexity in human tissue models of cancer. Adv. Drug Deliv. Rev.184, 114181 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2851_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"J-L Teillaud","year":"2024","unstructured":"Teillaud, J.-L., Houel, A., Panouillot, M., Riffard, C. & Dieu-Nosjean, M.-C. Tertiary lymphoid structures in anticancer immunity. Nat. Rev. Cancer24, 629\u2013646 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR22","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/all.14612","volume":"76","author":"Z-Z Wang","year":"2021","unstructured":"Wang, Z.-Z. et al. Stromal cells and B cells orchestrate ectopic lymphoid tissue formation in nasal polyps. Allergy76, 1416\u20131431 (2021).","journal-title":"Allergy"},{"key":"2851_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1378844","volume":"7","author":"F Posch","year":"2018","unstructured":"Posch, F. et al. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Oncoimmunology7, e1378844 (2018).","journal-title":"Oncoimmunology"},{"key":"2851_CR24","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","volume":"71","author":"L de Chaisemartin","year":"2011","unstructured":"de Chaisemartin, L. et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res.71, 6391\u20136399 (2011).","journal-title":"Cancer Res."},{"key":"2851_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan, M. et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity55, 527\u2013541.e5 (2022).","journal-title":"Immunity"},{"key":"2851_CR26","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","volume":"189","author":"C Germain","year":"2014","unstructured":"Germain, C. et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am. J. Respir. Crit. Care Med.189, 832\u2013844 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2851_CR27","doi-asserted-by":"publisher","first-page":"e002273","DOI":"10.1136\/jitc-2020-002273","volume":"9","author":"KT Lynch","year":"2021","unstructured":"Lynch, K. T. et al. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma. J. Immunother. Cancer9, e002273 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2851_CR28","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","volume":"54","author":"AE Overacre-Delgoffe","year":"2021","unstructured":"Overacre-Delgoffe, A. E. et al. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. Immunity54, 2812\u20132824.e4 (2021).","journal-title":"Immunity"},{"key":"2851_CR29","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s42003-022-04356-y","volume":"5","author":"P Devi-Marulkar","year":"2022","unstructured":"Devi-Marulkar, P. et al. Regulatory T cells infiltrate the tumor-induced tertiary lympho\u00efd structures and are associated with poor clinical outcome in NSCLC. Commun. Biol.5, 1416 (2022).","journal-title":"Commun. Biol."},{"key":"2851_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/2326-6066.CIR-17-0131","volume":"5","author":"EJ Colbeck","year":"2017","unstructured":"Colbeck, E. J. et al. Treg depletion licenses T cell-driven HEV neogenesis and promotes tumor destruction. Cancer Immunol. Res.5, 1005\u20131015 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"2851_CR31","doi-asserted-by":"publisher","first-page":"4832543","DOI":"10.1155\/2016\/4832543","volume":"2016","author":"DN He","year":"2016","unstructured":"He, D. N., Chen, W. L., Long, K. X., Zhang, X. & Dong, G. F. Association of serum CXCL13 with intrarenal ectopic lymphoid tissue formation in lupus nephritis. J. Immunol. Res.2016, 4832543 (2016).","journal-title":"J. Immunol. Res."},{"key":"2851_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/cvr\/cvt263","volume":"101","author":"K Guedj","year":"2014","unstructured":"Guedj, K. et al. M1 macrophages act as LT\u03b2R-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Cardiovasc. Res.101, 434\u2013443 (2014).","journal-title":"Cardiovasc. Res."},{"key":"2851_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12931-017-0641-7","volume":"18","author":"E Briend","year":"2017","unstructured":"Briend, E. et al. IL-18 associated with lung lymphoid aggregates drives IFN\u03b3 production in severe COPD. Respir. Res.18, 159 (2017).","journal-title":"Respir. Res."},{"key":"2851_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.26448","volume":"92","author":"R Magliozzi","year":"2022","unstructured":"Magliozzi, R. et al. \u2018Ependymal-in\u2019 gradient of thalamic damage in progressive multiple sclerosis. Ann. Neurol.92, 670\u2013685 (2022).","journal-title":"Ann. Neurol."},{"key":"2851_CR35","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1016\/j.ajpath.2016.07.026","volume":"186","author":"GJ Randolph","year":"2016","unstructured":"Randolph, G. J. et al. Lymphoid aggregates remodel lymphatic collecting vessels that serve mesenteric lymph nodes in Crohn disease. Am. J. Pathol.186, 3066\u20133073 (2016).","journal-title":"Am. J. Pathol."},{"key":"2851_CR36","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell175, 984\u2013997.e24 (2018).","journal-title":"Cell"},{"key":"2851_CR37","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","volume":"56","author":"T Taifour","year":"2023","unstructured":"Taifour, T. et al. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity56, 2755\u20132772.e8 (2023).","journal-title":"Immunity"},{"key":"2851_CR38","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1126\/science.286.5447.2098","volume":"286","author":"JG Cyster","year":"1999","unstructured":"Cyster, J. G. Chemokines and cell migration in secondary lymphoid organs. Science286, 2098\u20132102 (1999).","journal-title":"Science"},{"key":"2851_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.immunol.23.021704.115628","volume":"23","author":"JG Cyster","year":"2005","unstructured":"Cyster, J. G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol.23, 127\u2013159 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"2851_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev-cellbio-111315-125306","volume":"32","author":"HR Neely","year":"2016","unstructured":"Neely, H. R. & Flajnik, M. F. Emergence and evolution of secondary lymphoid organs. Annu. Rev. Cell Dev. Biol.32, 693\u2013711 (2016).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2851_CR41","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1172\/JCI97973","volume":"128","author":"C Wu","year":"2018","unstructured":"Wu, C. et al. Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis. J. Clin. Invest.128, 3425\u20133438 (2018).","journal-title":"J. Clin. Invest."},{"key":"2851_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.111.061986","volume":"125","author":"CS Robbins","year":"2012","unstructured":"Robbins, C. S. et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation125, 364\u2013374 (2012).","journal-title":"Circulation"},{"key":"2851_CR43","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.immuni.2012.08.025","volume":"37","author":"T Griseri","year":"2012","unstructured":"Griseri, T., McKenzie, B. S., Schiering, C. & Powrie, F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity37, 1116\u20131129 (2012).","journal-title":"Immunity"},{"key":"2851_CR44","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","volume":"39","author":"V Bronte","year":"2013","unstructured":"Bronte, V. & Pittet, M. J. The spleen in local and systemic regulation of immunity. Immunity39, 806\u2013818 (2013).","journal-title":"Immunity"},{"key":"2851_CR45","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.immuni.2012.10.015","volume":"38","author":"V Cortez-Retamozo","year":"2013","unstructured":"Cortez-Retamozo, V. et al. Angiotensin II drives the production of tumor-promoting macrophages. Immunity38, 296\u2013308 (2013).","journal-title":"Immunity"},{"key":"2851_CR46","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.7150\/thno.111116","volume":"15","author":"W Dong","year":"2025","unstructured":"Dong, W. et al. Targeted spleen modulation: a novel strategy for next-generation disease immunotherapy. Theranostics15, 4416\u20134445 (2025).","journal-title":"Theranostics"},{"key":"2851_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1126\/science.1215173","volume":"335","author":"PJ Rauch","year":"2012","unstructured":"Rauch, P. J. et al. Innate response activator B cells protect against microbial sepsis. Science335, 597\u2013601 (2012).","journal-title":"Science"},{"key":"2851_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1084\/jem.20081385","volume":"206","author":"C Auffray","year":"2009","unstructured":"Auffray, C. et al. CX3CR1+ CD115+ CD135+ common macrophage\/DC precursors and the role of CX3CR1 in their response to inflammation. J. Exp. Med.206, 595\u2013606 (2009).","journal-title":"J. Exp. Med."},{"key":"2851_CR49","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.immuni.2008.09.017","volume":"29","author":"S-J Kang","year":"2008","unstructured":"Kang, S.-J., Liang, H.-E., Reizis, B. & Locksley, R. M. Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells. Immunity29, 819\u2013833 (2008).","journal-title":"Immunity"},{"key":"2851_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity39, 1\u201310 (2013).","journal-title":"Immunity"},{"key":"2851_CR51","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1016\/j.celrep.2019.02.042","volume":"26","author":"K Veerman","year":"2019","unstructured":"Veerman, K., Tardiveau, C., Martins, F., Coudert, J. & Girard, J.-P. Single-cell analysis reveals heterogeneity of high endothelial venules and different regulation of genes controlling lymphocyte entry to lymph nodes. Cell Rep.26, 3116\u20133131.e5 (2019).","journal-title":"Cell Rep."},{"key":"2851_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","volume":"55","author":"RA Chaurio","year":"2022","unstructured":"Chaurio, R. A. et al. TGF-\u03b2-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures. Immunity55, 115\u2013128.e9 (2022).","journal-title":"Immunity"},{"key":"2851_CR53","doi-asserted-by":"publisher","first-page":"101481","DOI":"10.1016\/j.smim.2021.101481","volume":"52","author":"AE Marciscano","year":"2021","unstructured":"Marciscano, A. E. & Anandasabapathy, N. The role of dendritic cells in cancer and anti-tumor immunity. Semin. Immunol.52, 101481 (2021).","journal-title":"Semin. Immunol."},{"key":"2851_CR54","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature10540","volume":"479","author":"C Moussion","year":"2011","unstructured":"Moussion, C. & Girard, J.-P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature479, 542\u2013546 (2011).","journal-title":"Nature"},{"key":"2851_CR55","doi-asserted-by":"crossref","unstructured":"Sl, T., Jm, T. & Dm, P. Neoadjuvant checkpoint blockade for cancer immunotherapy. Science367, eaax0182 (2020).","DOI":"10.1126\/science.aax0182"},{"key":"2851_CR56","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","volume":"56","author":"MJ Pittet","year":"2023","unstructured":"Pittet, M. J., Di Pilato, M., Garris, C. & Mempel, T. R. Dendritic cells as shepherds of T cell immunity in cancer. Immunity56, 2218\u20132230 (2023).","journal-title":"Immunity"},{"key":"2851_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq1405","volume":"388","author":"K Jobin","year":"2025","unstructured":"Jobin, K. et al. A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals. Science388, eadq1405 (2025).","journal-title":"Science"},{"key":"2851_CR58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature02284","volume":"427","author":"M Matloubian","year":"2004","unstructured":"Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature427, 355\u2013360 (2004).","journal-title":"Nature"},{"key":"2851_CR59","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1073\/pnas.1516485113","volume":"113","author":"AP Benechet","year":"2016","unstructured":"Benechet, A. P. et al. T cell-intrinsic S1PR1 regulates endogenous effector T-cell egress dynamics from lymph nodes during infection. Proc. Natl. Acad. Sci. USA.113, 2182\u20132187 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2851_CR60","doi-asserted-by":"publisher","first-page":"109368","DOI":"10.1016\/j.celrep.2021.109368","volume":"36","author":"M Okuniewska","year":"2021","unstructured":"Okuniewska, M. et al. SPNS2 enables T cell egress from lymph nodes during an immune response. Cell Rep.36, 109368 (2021).","journal-title":"Cell Rep."},{"key":"2851_CR61","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1126\/science.1208248","volume":"333","author":"TI Arnon","year":"2011","unstructured":"Arnon, T. I. et al. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science333, 1898\u20131903 (2011).","journal-title":"Science"},{"key":"2851_CR62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2006.04.017","volume":"25","author":"RS Allan","year":"2006","unstructured":"Allan, R. S. et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity25, 153\u2013162 (2006).","journal-title":"Immunity"},{"key":"2851_CR63","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.immuni.2022.07.019","volume":"55","author":"MA Ataide","year":"2022","unstructured":"Ataide, M. A. et al. Lymphatic migration of unconventional T cells promotes site-specific immunity in distinct lymph nodes. Immunity55, 1813\u20131828.e9 (2022).","journal-title":"Immunity"},{"key":"2851_CR64","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.immuni.2023.07.008","volume":"56","author":"H Brown","year":"2023","unstructured":"Brown, H., Komnick, M. R., Brigleb, P. H., Dermody, T. S. & Esterh\u00e1zy, D. Lymph node sharing between pancreas, gut, and liver leads to immune crosstalk and regulation of pancreatic autoimmunity. Immunity56, 2070\u20132085.e11 (2023).","journal-title":"Immunity"},{"key":"2851_CR65","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41590-021-00948-8","volume":"22","author":"M Hiltensperger","year":"2021","unstructured":"Hiltensperger, M. et al. Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity. Nat. Immunol.22, 880\u2013892 (2021).","journal-title":"Nat. Immunol."},{"key":"2851_CR66","doi-asserted-by":"publisher","first-page":"20635","DOI":"10.1073\/pnas.1905762116","volume":"116","author":"L Hou","year":"2019","unstructured":"Hou, L. et al. SerpinB1 controls encephalitogenic T helper cells in neuroinflammation. Proc. Natl. Acad. Sci. USA.116, 20635\u201320643 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2851_CR67","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008026","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy. J. Immunother. Cancer12, e008026 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2851_CR68","doi-asserted-by":"crossref","unstructured":"Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell185, 4049\u20134066 (2022).","DOI":"10.1016\/j.cell.2022.09.020"},{"key":"2851_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg7836","volume":"6","author":"KA Connolly","year":"2021","unstructured":"Connolly, K. A. et al. A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol.6, eabg7836 (2021).","journal-title":"Sci. Immunol."},{"key":"2851_CR70","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","volume":"56","author":"N Prokhnevska","year":"2023","unstructured":"Prokhnevska, N. et al. CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity56, 107\u2013124.e5 (2023).","journal-title":"Immunity"},{"key":"2851_CR71","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim, M. K. et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell186, 1127\u20131143.e18 (2023).","journal-title":"Cell"},{"key":"2851_CR72","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","volume":"25","author":"Y Gu","year":"2019","unstructured":"Gu, Y. et al. Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG. Nat. Med.25, 312\u2013322 (2019).","journal-title":"Nat. Med."},{"key":"2851_CR73","doi-asserted-by":"publisher","first-page":"110447","DOI":"10.1016\/j.celrep.2022.110447","volume":"38","author":"K Kos","year":"2022","unstructured":"Kos, K. et al. Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche. Cell Rep.38, 110447 (2022).","journal-title":"Cell Rep."},{"key":"2851_CR74","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41392-023-01576-4","volume":"8","author":"H Ji","year":"2023","unstructured":"Ji, H. et al. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct. Target. Ther.8, 367 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2851_CR75","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","volume":"185","author":"NE Reticker-Flynn","year":"2022","unstructured":"Reticker-Flynn, N. E. et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell185, 1924\u20131942.e23 (2022).","journal-title":"Cell"},{"key":"2851_CR76","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1172\/JCI73530","volume":"124","author":"F Ogawa","year":"2014","unstructured":"Ogawa, F. et al. Prostanoid induces premetastatic niche in regional lymph nodes. J. Clin. Invest.124, 4882\u20134894 (2014).","journal-title":"J. Clin. Invest."},{"key":"2851_CR77","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cell.2020.06.001","volume":"182","author":"AM Luoma","year":"2020","unstructured":"Luoma, A. M. et al. Molecular pathways of colon inflammation induced by cancer immunotherapy. Cell182, 655\u2013671.e22 (2020).","journal-title":"Cell"},{"key":"2851_CR78","doi-asserted-by":"publisher","first-page":"1447021","DOI":"10.3389\/fimmu.2024.1447021","volume":"15","author":"S Keam","year":"2024","unstructured":"Keam, S. et al. Toxicity in the era of immune checkpoint inhibitor therapy. Front. Immunol.15, 1447021 (2024).","journal-title":"Front. Immunol."},{"key":"2851_CR79","doi-asserted-by":"crossref","unstructured":"Engblom, C., Pfirschke, C. & Pittet, M. J. The role of myeloid cells in cancer therapies. Nat. Rev. Cancer16, 447\u2013462 (2016).","DOI":"10.1038\/nrc.2016.54"},{"key":"2851_CR80","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ncb3346","volume":"18","author":"EM Pietras","year":"2016","unstructured":"Pietras, E. M. et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat. Cell Biol.18, 607\u2013618 (2016).","journal-title":"Nat. Cell Biol."},{"key":"2851_CR81","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41590-019-0402-5","volume":"20","author":"T Chavakis","year":"2019","unstructured":"Chavakis, T., Mitroulis, I. & Hajishengallis, G. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat. Immunol.20, 802\u2013811 (2019).","journal-title":"Nat. Immunol."},{"key":"2851_CR82","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.stem.2024.09.010","volume":"31","author":"TS Mills","year":"2024","unstructured":"Mills, T. S. et al. A distinct metabolic and epigenetic state drives trained immunity in HSC-derived macrophages from autoimmune mice. Cell Stem. Cell31, 1630\u20131649.e8 (2024).","journal-title":"Cell Stem. Cell"},{"key":"2851_CR83","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1172\/JCI68189","volume":"123","author":"JD Waight","year":"2013","unstructured":"Waight, J. D. et al. Myeloid-derived suppressor cell development is regulated by a STAT\/IRF-8 axis. J. Clin. Invest.123, 4464\u20134478 (2013).","journal-title":"J. Clin. Invest."},{"key":"2851_CR84","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister, S. S. & Weinberg, R. A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell Biol.16, 717\u2013727 (2014).","journal-title":"Nat. Cell Biol."},{"key":"2851_CR85","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia, F., Sanseviero, E. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol.21, 485\u2013498 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03600-6","volume":"9","author":"MA Meyer","year":"2018","unstructured":"Meyer, M. A. et al. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance. Nat. Commun.9, 1250 (2018).","journal-title":"Nat. Commun."},{"key":"2851_CR87","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.stem.2023.04.005","volume":"30","author":"X Hao","year":"2023","unstructured":"Hao, X. et al. Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. Cell Stem. Cell30, 648\u2013664.e8 (2023).","journal-title":"Cell Stem. Cell"},{"key":"2851_CR88","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41591-018-0030-x","volume":"24","author":"M Maryanovich","year":"2018","unstructured":"Maryanovich, M. et al. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nat. Med.24, 782\u2013791 (2018).","journal-title":"Nat. Med."},{"key":"2851_CR89","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood-2004-11-4282","volume":"106","author":"Y Liang","year":"2005","unstructured":"Liang, Y., Van Zant, G. & Szilvassy, S. J. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood106, 1479\u20131487 (2005).","journal-title":"Blood"},{"key":"2851_CR90","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1210\/jc.2012-3634","volume":"98","author":"PK Fazeli","year":"2013","unstructured":"Fazeli, P. K. et al. Marrow fat and bone-new perspectives. J. Clin. Endocrinol. Metab.98, 935\u2013945 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2851_CR91","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stem.2017.02.009","volume":"20","author":"TH Ambrosi","year":"2017","unstructured":"Ambrosi, T. H. et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration. Cell Stem. Cell20, 771\u2013784.e6 (2017).","journal-title":"Cell Stem. Cell"},{"key":"2851_CR92","doi-asserted-by":"publisher","first-page":"848925","DOI":"10.3389\/fragi.2022.848925","volume":"3","author":"L Duong","year":"2022","unstructured":"Duong, L., Pixley, F. J., Nelson, D. J. & Jackaman, C. Aging leads to increased monocytes and macrophages with altered CSF-1 receptor expression and earlier tumor-associated macrophage expansion in murine mesothelioma. Front. Aging3, 848925 (2022).","journal-title":"Front. Aging"},{"key":"2851_CR93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41590-021-01083-0","volume":"23","author":"E Blacher","year":"2022","unstructured":"Blacher, E. et al. Aging disrupts circadian gene regulation and function in macrophages. Nat. Immunol.23, 229\u2013236 (2022).","journal-title":"Nat. Immunol."},{"key":"2851_CR94","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg, H., Adolph, T. E. & Trauner, M. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metab.34, 1700\u20131718 (2022).","journal-title":"Cell Metab."},{"key":"2851_CR95","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1126\/science.abi6087","volume":"374","author":"G Agirman","year":"2021","unstructured":"Agirman, G., Yu, K. B. & Hsiao, E. Y. Signaling inflammation across the gut-brain axis. Science374, 1087\u20131092 (2021).","journal-title":"Science"},{"key":"2851_CR96","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41575-022-00663-1","volume":"20","author":"Z S","year":"2023","unstructured":"S, Z. et al. Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation. Nat. Rev. Gastroenterol. Hepatol.20, 50\u201364 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2851_CR97","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jcmgh.2020.12.003","volume":"11","author":"A Schippers","year":"2021","unstructured":"Schippers, A. et al. MAdCAM-1\/\u03b14\u03b27 integrin-mediated lymphocyte\/endothelium interactions exacerbate acute immune-mediated hepatitis in mice. Cell. Mol. Gastroenterol. Hepatol.11, 1227\u20131250.e1 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"2851_CR98","doi-asserted-by":"publisher","first-page":"100054","DOI":"10.1016\/j.jtauto.2020.100054","volume":"3","author":"M de Krijger","year":"2020","unstructured":"de Krijger, M. et al. Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease. J. Transl. Autoimmun.3, 100054 (2020).","journal-title":"J. Transl. Autoimmun."},{"key":"2851_CR99","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/hep.24816","volume":"55","author":"K Neumann","year":"2012","unstructured":"Neumann, K. et al. Connecting liver and gut: murine liver sinusoidal endothelium induces gut tropism of CD4+ T cells via retinoic acid. Hepatology55, 1976\u20131984 (2012).","journal-title":"Hepatology"},{"key":"2851_CR100","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cyto.2017.07.007","volume":"99","author":"M Kim","year":"2017","unstructured":"Kim, M. et al. TNF\u03b1 and IL-1\u03b2 in the synovial fluid facilitate mucosal-associated invariant T (MAIT) cell migration. Cytokine99, 91\u201398 (2017).","journal-title":"Cytokine"},{"key":"2851_CR101","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","volume":"590","author":"LM Sanmarco","year":"2021","unstructured":"Sanmarco, L. M. et al. Gut-licensed IFN\u03b3+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes. Nature590, 473\u2013479 (2021).","journal-title":"Nature"},{"key":"2851_CR102","doi-asserted-by":"crossref","unstructured":"Ry, S. et al. Trafficking circuit of CD8+ T cells between the intestine and bone marrow governs antitumour immunity. Nat. Cell Biol. 26, 1346\u20131358 (2024).","DOI":"10.1038\/s41556-024-01462-3"},{"key":"2851_CR103","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157340","volume":"132","author":"S Pal","year":"2022","unstructured":"Pal, S. et al. The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone. J. Clin. Invest.132, e157340 (2022).","journal-title":"J. Clin. Invest."},{"key":"2851_CR104","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.immuni.2024.05.021","volume":"57","author":"RB Delconte","year":"2024","unstructured":"Delconte, R. B. et al. Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity. Immunity57, 1923\u20131938.e7 (2024).","journal-title":"Immunity"},{"key":"2851_CR105","doi-asserted-by":"crossref","unstructured":"Nagai, M. et al. Fasting-refeeding impacts immune cell dynamics and mucosal immune responses. Cell178, 1072\u20131087 (2019).","DOI":"10.1016\/j.cell.2019.07.047"},{"key":"2851_CR106","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman, W. H., Pag\u00e8s, F., Saut\u00e8s-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer12, 298\u2013306 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR107","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","volume":"623","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature623, 616\u2013624 (2023).","journal-title":"Nature"},{"key":"2851_CR108","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity48, 812\u2013830.e14 (2018).","journal-title":"Immunity"},{"key":"2851_CR109","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12931-021-01619-w","volume":"22","author":"F Schleich","year":"2021","unstructured":"Schleich, F. et al. Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping. Respir. Res.22, 15 (2021).","journal-title":"Respir. Res."},{"key":"2851_CR110","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201730","volume":"218","author":"HK Chung","year":"2021","unstructured":"Chung, H. K., McDonald, B. & Kaech, S. M. The architectural design of CD8+ T cell responses in acute and chronic infection: parallel structures with divergent fates. J. Exp. Med.218, e20201730 (2021).","journal-title":"J. Exp. Med."},{"key":"2851_CR111","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2022","unstructured":"Philip, M. & Schietinger, A. CD8+ T cell differentiation and dysfunction in cancer. Nat. Rev. Immunol.22, 209\u2013223 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR112","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.molcel.2021.03.045","volume":"81","author":"Y Pritykin","year":"2021","unstructured":"Pritykin, Y. et al. A unified atlas of CD8 T cell dysfunctional states in cancer and infection. Mol. Cell81, 2477\u20132493.e10 (2021).","journal-title":"Mol. Cell"},{"key":"2851_CR113","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.ymthe.2023.08.015","volume":"31","author":"R Ballet","year":"2023","unstructured":"Ballet, R. et al. Chemerin triggers migration of a CD8 T cell subset with natural killer cell functions. Mol. Ther. J. Am. Soc. Gene Ther.31, 2887\u20132900 (2023).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"2851_CR114","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2148850","volume":"11","author":"H Forkel","year":"2022","unstructured":"Forkel, H. et al. BCL11B depletion induces the development of highly cytotoxic innate T cells out of IL-15 stimulated peripheral blood \u03b1\u03b2 CD8+ T cells. Oncoimmunology11, 2148850 (2022).","journal-title":"Oncoimmunology"},{"key":"2851_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg0675","volume":"15","author":"MG Lechner","year":"2023","unstructured":"Lechner, M. G. et al. Clonally expanded, thyrotoxic effector CD8+ T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis. Sci. Transl. Med.15, eadg0675 (2023).","journal-title":"Sci. Transl. Med."},{"key":"2851_CR116","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1172\/JCI132531","volume":"130","author":"CA Wagner","year":"2020","unstructured":"Wagner, C. A., Roqu\u00e9, P. J., Mileur, T. R., Liggitt, D. & Goverman, J. M. Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity. J. Clin. Invest.130, 203\u2013213 (2020).","journal-title":"J. Clin. Invest."},{"key":"2851_CR117","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.immuni.2020.09.005","volume":"53","author":"D Pais Ferreira","year":"2020","unstructured":"Pais Ferreira, D. et al. Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation. Immunity53, 985\u20131000.e11 (2020).","journal-title":"Immunity"},{"key":"2851_CR118","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41590-022-01171-9","volume":"23","author":"K Bresser","year":"2022","unstructured":"Bresser, K. et al. Replicative history marks transcriptional and functional disparity in the CD8+ T cell memory pool. Nat. Immunol.23, 791\u2013801 (2022).","journal-title":"Nat. Immunol."},{"key":"2851_CR119","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12964-025-02069-3","volume":"23","author":"Q Xu","year":"2025","unstructured":"Xu, Q. et al. Intrinsic STING of CD8\u2009+\u2009T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects. Cell Commun. Signal. CCS23, 99 (2025).","journal-title":"Cell Commun. Signal. CCS"},{"key":"2851_CR120","doi-asserted-by":"crossref","unstructured":"Tang, X. et al. Glycolysis inhibition induces anti-tumor central memory CD8+T cell differentiation upon combination with microwave ablation therapy. Nat. Commun. 15, 4665 (2024).","DOI":"10.1038\/s41467-024-49059-6"},{"key":"2851_CR121","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41590-022-01379-9","volume":"24","author":"PDA Vignali","year":"2023","unstructured":"Vignali, P. D. A. et al. Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. Nat. Immunol.24, 267\u2013279 (2023).","journal-title":"Nat. Immunol."},{"key":"2851_CR122","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","volume":"576","author":"CS Jansen","year":"2019","unstructured":"Jansen, C. S. et al. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature576, 465\u2013470 (2019).","journal-title":"Nature"},{"key":"2851_CR123","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211538","volume":"219","author":"C Ma","year":"2022","unstructured":"Ma, C. et al. TGF-\u03b2 promotes stem-like T cells via enforcing their lymphoid tissue retention. J. Exp. Med.219, e20211538 (2022).","journal-title":"J. Exp. Med."},{"key":"2851_CR124","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","volume":"50","author":"MT Chow","year":"2019","unstructured":"Chow, M. T. et al. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy. Immunity50, 1498\u20131512.e5 (2019).","journal-title":"Immunity"},{"key":"2851_CR125","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","volume":"185","author":"AM Luoma","year":"2022","unstructured":"Luoma, A. M. et al. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. Cell185, 2918\u20132935.e29 (2022).","journal-title":"Cell"},{"key":"2851_CR126","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-pathol-011110-130318","volume":"8","author":"CT Weaver","year":"2013","unstructured":"Weaver, C. T., Elson, C. O., Fouser, L. A. & Kolls, J. K. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol.8, 477\u2013512 (2013).","journal-title":"Annu. Rev. Pathol."},{"key":"2851_CR127","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","volume":"535","author":"K Honda","year":"2016","unstructured":"Honda, K. & Littman, D. R. The microbiota in adaptive immune homeostasis and disease. Nature535, 75\u201384 (2016).","journal-title":"Nature"},{"key":"2851_CR128","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","volume":"32","author":"H-J Wu","year":"2010","unstructured":"Wu, H.-J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity32, 815\u2013827 (2010).","journal-title":"Immunity"},{"key":"2851_CR129","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","volume":"13","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol.13, 991\u2013999 (2012).","journal-title":"Nat. Immunol."},{"key":"2851_CR130","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41392-022-00895-2","volume":"7","author":"R Sun","year":"2022","unstructured":"Sun, R. et al. Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40\/OX40L-mediated interaction with Th17 cells. Signal Transduct. Target. Ther.7, 80 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2851_CR131","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/0008-5472.CAN-23-2123","volume":"84","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Th17 cells secrete TWEAK to trigger epithelial-mesenchymal transition and promote colorectal cancer liver metastasis. Cancer Res.84, 1352\u20131371 (2024).","journal-title":"Cancer Res."},{"key":"2851_CR132","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","volume":"50","author":"S Crotty","year":"2019","unstructured":"Crotty, S. T follicular helper cell biology: a decade of discovery and diseases. Immunity50, 1132\u20131148 (2019).","journal-title":"Immunity"},{"key":"2851_CR133","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev-immunol-101819-025146","volume":"39","author":"X Yin","year":"2021","unstructured":"Yin, X., Chen, S. & Eisenbarth, S. C. Dendritic cell regulation of T helper cells. Annu. Rev. Immunol.39, 759\u2013790 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"2851_CR134","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41577-022-00693-5","volume":"22","author":"LSK Walker","year":"2022","unstructured":"Walker, L. S. K. The link between circulating follicular helper T cells and autoimmunity. Nat. Rev. Immunol.22, 567\u2013575 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR135","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita, R. et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity34, 108\u2013121 (2011).","journal-title":"Immunity"},{"key":"2851_CR136","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1172\/JCI125628","volume":"129","author":"LA Vella","year":"2019","unstructured":"Vella, L. A. et al. T follicular helper cells in human efferent lymph retain lymphoid characteristics. J. Clin. Invest.129, 3185\u20133200 (2019).","journal-title":"J. Clin. Invest."},{"key":"2851_CR137","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez, A. et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat. Med.27, 820\u2013832 (2021).","journal-title":"Nat. Med."},{"key":"2851_CR138","doi-asserted-by":"publisher","first-page":"110331","DOI":"10.1016\/j.celrep.2022.110331","volume":"38","author":"J Nagasaki","year":"2022","unstructured":"Nagasaki, J. et al. PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes. Cell Rep.38, 110331 (2022).","journal-title":"Cell Rep."},{"key":"2851_CR139","doi-asserted-by":"publisher","first-page":"e002157","DOI":"10.1136\/jitc-2020-002157","volume":"9","author":"J Niogret","year":"2021","unstructured":"Niogret, J. et al. Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1\/PD-1 efficacy. J. Immunother. Cancer9, e002157 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2851_CR140","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","volume":"24","author":"CM Wardell","year":"2025","unstructured":"Wardell, C. M., Boardman, D. A. & Levings, M. K. Harnessing the biology of regulatory T cells to treat disease. Nat. Rev. Drug Discov.24, 93\u2013111 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2851_CR141","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.immuni.2024.05.023","volume":"57","author":"OT Burton","year":"2024","unstructured":"Burton, O. T. et al. The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program. Immunity57, 1586\u20131602.e10 (2024).","journal-title":"Immunity"},{"key":"2851_CR142","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abk0957","volume":"7","author":"K Itahashi","year":"2022","unstructured":"Itahashi, K. et al. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors. Sci. Immunol.7, eabk0957 (2022).","journal-title":"Sci. Immunol."},{"key":"2851_CR143","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.immuni.2019.12.002","volume":"52","author":"M Delacher","year":"2020","unstructured":"Delacher, M. et al. Precursors for nonlymphoid-tissue treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF. Immunity52, 295\u2013312.e11 (2020).","journal-title":"Immunity"},{"key":"2851_CR144","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41423-020-00547-x","volume":"18","author":"R Sakai","year":"2021","unstructured":"Sakai, R. et al. Kidney GATA3+ regulatory T cells play roles in the convalescence stage after antibody-mediated renal injury. Cell. Mol. Immunol.18, 1249\u20131261 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"2851_CR145","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","volume":"21","author":"S Kumagai","year":"2024","unstructured":"Kumagai, S., Itahashi, K. & Nishikawa, H. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine. Nat. Rev. Clin. Oncol.21, 337\u2013353 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2851_CR146","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","volume":"30","author":"N Ohkura","year":"2020","unstructured":"Ohkura, N. & Sakaguchi, S. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Cell Res.30, 465\u2013474 (2020).","journal-title":"Cell Res."},{"key":"2851_CR147","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med.10, 942\u2013949 (2004).","journal-title":"Nat. Med."},{"key":"2851_CR148","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-20-2133","volume":"81","author":"A Adamczyk","year":"2021","unstructured":"Adamczyk, A. et al. GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancer. Cancer Res.81, 2970\u20132982 (2021).","journal-title":"Cancer Res."},{"key":"2851_CR149","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/imm.13337","volume":"163","author":"SK Whiteside","year":"2021","unstructured":"Whiteside, S. K. et al. CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function. Immunology163, 512\u2013520 (2021).","journal-title":"Immunology"},{"key":"2851_CR150","doi-asserted-by":"crossref","unstructured":"Zhou, J. et al. CCR1hi\/CCL5hi macrophage-mediated CCL5hi T cell chemotaxis in salivary gland aggravates Sj\u00f6gren\u2019s syndrome. J. Adv. Res. 82, 507\u2013520 (2026).","DOI":"10.1016\/j.jare.2025.06.076"},{"key":"2851_CR151","doi-asserted-by":"publisher","first-page":"102684","DOI":"10.1016\/j.jaut.2021.102684","volume":"123","author":"JC Graver","year":"2021","unstructured":"Graver, J. C. et al. Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica. J. Autoimmun.123, 102684 (2021).","journal-title":"J. Autoimmun."},{"key":"2851_CR152","doi-asserted-by":"publisher","first-page":"111295","DOI":"10.1016\/j.celrep.2022.111295","volume":"40","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers. Cell Rep.40, 111295 (2022).","journal-title":"Cell Rep."},{"key":"2851_CR153","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.gastro.2017.09.045","volume":"154","author":"R Liu","year":"2018","unstructured":"Liu, R. et al. MicroRNAs 15A and 16-1 activate signaling pathways that mediate chemotaxis of immune regulatory B cells to colorectal tumors. Gastroenterology154, 637\u2013651.e7 (2018).","journal-title":"Gastroenterology"},{"key":"2851_CR154","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","volume":"80","author":"S Das","year":"2020","unstructured":"Das, S., Shapiro, B., Vucic, E. A., Vogt, S. & Bar-Sagi, D. Tumor cell-derived IL1\u03b2 promotes desmoplasia and immune suppression in pancreatic cancer. Cancer Res.80, 1088\u20131101 (2020).","journal-title":"Cancer Res."},{"key":"2851_CR155","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2326-6066.CIR-19-0349","volume":"8","author":"B Mirlekar","year":"2020","unstructured":"Mirlekar, B. et al. B cell-derived IL35 drives STAT3-dependent CD8+ T-cell exclusion in pancreatic cancer. Cancer Immunol. Res.8, 292\u2013308 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"2851_CR156","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.immuni.2022.04.017","volume":"55","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion. Immunity55, 1067\u20131081.e8 (2022).","journal-title":"Immunity"},{"key":"2851_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02338-1","volume":"18","author":"C Prado","year":"2021","unstructured":"Prado, C. et al. Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity. J. Neuroinflammation18, 292 (2021).","journal-title":"J. Neuroinflammation"},{"key":"2851_CR158","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00401-023-02552-6","volume":"145","author":"A Geladaris","year":"2023","unstructured":"Geladaris, A. et al. IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity. Acta Neuropathol.145, 461\u2013477 (2023).","journal-title":"Acta Neuropathol."},{"key":"2851_CR159","doi-asserted-by":"publisher","first-page":"103326","DOI":"10.1016\/j.jaut.2024.103326","volume":"149","author":"Q-Y Su","year":"2024","unstructured":"Su, Q.-Y., Jiang, Z.-Q., Song, X.-Y. & Zhang, S.-X. Regulatory B cells in autoimmune diseases: Insights and therapeutic potential. J. Autoimmun.149, 103326 (2024).","journal-title":"J. Autoimmun."},{"key":"2851_CR160","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nri.2016.116","volume":"17","author":"T Worbs","year":"2017","unstructured":"Worbs, T., Hammerschmidt, S. I. & F\u00f6rster, R. Dendritic cell migration in health and disease. Nat. Rev. Immunol.17, 30\u201348 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63559-z","volume":"16","author":"FT Hager","year":"2025","unstructured":"Hager, F. T. et al. Progressive changes in phenotype, transcriptome and proliferation capacity characterise continued maturation and migration of intestinal cDCs in homeostasis. Nat. Commun.16, 8204 (2025).","journal-title":"Nat. Commun."},{"key":"2851_CR162","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","volume":"20","author":"A Del Prete","year":"2023","unstructured":"Del Prete, A. et al. Dendritic cell subsets in cancer immunity and tumor antigen sensing. Cell. Mol. Immunol.20, 432\u2013447 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"2851_CR163","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell172, 1022\u20131037.e14 (2018).","journal-title":"Cell"},{"key":"2851_CR164","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts, E. W. et al. Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell30, 324\u2013336 (2016).","journal-title":"Cancer Cell"},{"key":"2851_CR165","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq6352","volume":"8","author":"J Alladina","year":"2023","unstructured":"Alladina, J. et al. A human model of asthma exacerbation reveals transcriptional programs and cell circuits specific to allergic asthma. Sci. Immunol.8, eabq6352 (2023).","journal-title":"Sci. Immunol."},{"key":"2851_CR166","doi-asserted-by":"crossref","unstructured":"Cyc, L. et al. Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. Nat. Commun. 15, 682 (2024).","DOI":"10.1038\/s41467-024-44787-1"},{"key":"2851_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat. Commun.11, 5077 (2020).","journal-title":"Nat. Commun."},{"key":"2851_CR168","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","volume":"580","author":"B Maier","year":"2020","unstructured":"Maier, B. et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature580, 257\u2013262 (2020).","journal-title":"Nature"},{"key":"2851_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08180-0","volume":"16","author":"Z Xie","year":"2025","unstructured":"Xie, Z. et al. The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy. Cell Death Dis.16, 900 (2025).","journal-title":"Cell Death Dis."},{"key":"2851_CR170","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.7150\/thno.72760","volume":"12","author":"R-Q Yao","year":"2022","unstructured":"Yao, R.-Q. et al. Single-cell transcriptome profiling of the immune space-time landscape reveals dendritic cell regulatory program in polymicrobial sepsis. Theranostics12, 4606\u20134628 (2022).","journal-title":"Theranostics"},{"key":"2851_CR171","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1158\/2326-6066.CIR-21-0265","volume":"9","author":"C-Y Chen","year":"2021","unstructured":"Chen, C.-Y. et al. Combining an alarmin HMGN1 peptide with PD-L1 blockade results in robust antitumor effects with a concomitant increase of stem-like\/progenitor exhausted CD8+ T cells. Cancer Immunol. Res.9, 1214\u20131228 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"2851_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59341-w","volume":"16","author":"H Li","year":"2025","unstructured":"Li, H. et al. Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer. Nat. Commun.16, 4228 (2025).","journal-title":"Nat. Commun."},{"key":"2851_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37353-8","volume":"14","author":"I Nofech-Mozes","year":"2023","unstructured":"Nofech-Mozes, I., Soave, D., Awadalla, P. & Abelson, S. Pan-cancer classification of single cells in the tumour microenvironment. Nat. Commun.14, 1615 (2023).","journal-title":"Nat. Commun."},{"key":"2851_CR174","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.immuni.2007.01.017","volume":"26","author":"B Le\u00f3n","year":"2007","unstructured":"Le\u00f3n, B., L\u00f3pez-Bravo, M. & Ardav\u00edn, C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity26, 519\u2013531 (2007).","journal-title":"Immunity"},{"key":"2851_CR175","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.immuni.2012.08.026","volume":"37","author":"E Zigmond","year":"2012","unstructured":"Zigmond, E. et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity37, 1076\u20131090 (2012).","journal-title":"Immunity"},{"key":"2851_CR176","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1182\/blood-2010-07-295626","volume":"118","author":"V Sisirak","year":"2011","unstructured":"Sisirak, V. et al. CCR6\/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood118, 5130\u20135140 (2011).","journal-title":"Blood"},{"key":"2851_CR177","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-immunol-081022-113627","volume":"41","author":"LG Ng","year":"2023","unstructured":"Ng, L. G., Liu, Z., Kwok, I. & Ginhoux, F. Origin and heterogeneity of tissue myeloid cells: a focus on GMP-derived monocytes and neutrophils. Annu. Rev. Immunol.41, 375\u2013404 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"2851_CR178","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","volume":"53","author":"S Tran","year":"2020","unstructured":"Tran, S. et al. Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity53, 627\u2013640.e5 (2020).","journal-title":"Immunity"},{"key":"2851_CR179","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","volume":"184","author":"D Wendisch","year":"2021","unstructured":"Wendisch, D. et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell184, 6243\u20136261.e27 (2021).","journal-title":"Cell"},{"key":"2851_CR180","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.immuni.2021.03.005","volume":"54","author":"PA Szabo","year":"2021","unstructured":"Szabo, P. A. et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity54, 797\u2013814.e6 (2021).","journal-title":"Immunity"},{"key":"2851_CR181","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"B-Z Qian","year":"2011","unstructured":"Qian, B.-Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature475, 222\u2013225 (2011).","journal-title":"Nature"},{"key":"2851_CR182","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal4508","volume":"9","author":"Z Zheng","year":"2017","unstructured":"Zheng, Z. et al. Donor pulmonary intravascular nonclassical monocytes recruit recipient neutrophils and mediate primary lung allograft dysfunction. Sci. Transl. Med.9, eaal4508 (2017).","journal-title":"Sci. Transl. Med."},{"key":"2851_CR183","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1172\/JCI93182","volume":"127","author":"K Jung","year":"2017","unstructured":"Jung, K. et al. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. J. Clin. Invest.127, 3039\u20133051 (2017).","journal-title":"J. Clin. Invest."},{"key":"2851_CR184","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.aac9407","volume":"350","author":"RN Hanna","year":"2015","unstructured":"Hanna, R. N. et al. Patrolling monocytes control tumor metastasis to the lung. Science350, 985\u2013990 (2015).","journal-title":"Science"},{"key":"2851_CR185","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman, S., Lavine, K. J. & Randolph, G. J. Origin and functions of tissue macrophages. Immunity41, 21\u201335 (2014).","journal-title":"Immunity"},{"key":"2851_CR186","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri3671","volume":"14","author":"F Ginhoux","year":"2014","unstructured":"Ginhoux, F. & Jung, S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol.14, 392\u2013404 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR187","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1158\/2159-8290.CD-15-0012","volume":"5","author":"AS Harney","year":"2015","unstructured":"Harney, A. S. et al. Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discov.5, 932\u2013943 (2015).","journal-title":"Cancer Discov."},{"key":"2851_CR188","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2018.04.007","volume":"23","author":"EN Arwert","year":"2018","unstructured":"Arwert, E. N. et al. A unidirectional transition from migratory to perivascular macrophage is required for tumor cell intravasation. Cell Rep.23, 1239\u20131248 (2018).","journal-title":"Cell Rep."},{"key":"2851_CR189","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.devcel.2023.06.006","volume":"58","author":"JE Anstee","year":"2023","unstructured":"Anstee, J. E. et al. LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer. Dev. Cell58, 1548\u20131561.e10 (2023).","journal-title":"Dev. Cell"},{"key":"2851_CR190","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg9518","volume":"7","author":"JW Opzoomer","year":"2021","unstructured":"Opzoomer, J. W. et al. Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression. Sci. Adv.7, eabg9518 (2021).","journal-title":"Sci. Adv."},{"key":"2851_CR191","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","volume":"54","author":"S Hegde","year":"2021","unstructured":"Hegde, S., Leader, A. M. & Merad, M. MDSC: markers, development, states, and unaddressed complexity. Immunity54, 875\u2013884 (2021).","journal-title":"Immunity"},{"key":"2851_CR192","doi-asserted-by":"crossref","unstructured":"Bayik, D. et al. Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets. Cancer Res. 82, 4274\u20134287 (2022).","DOI":"10.1158\/0008-5472.CAN-21-3840"},{"key":"2851_CR193","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1158\/1078-0432.CCR-16-0870","volume":"23","author":"A Kalbasi","year":"2017","unstructured":"Kalbasi, A. et al. Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma. Clin. Cancer Res.23, 137\u2013148 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR194","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.3389\/fimmu.2019.03070","volume":"10","author":"C Siret","year":"2019","unstructured":"Siret, C. et al. Deciphering the crosstalk between myeloid-derived suppressor cells and regulatory T cells in pancreatic ductal adenocarcinoma. Front. Immunol.10, 3070 (2019).","journal-title":"Front. Immunol."},{"key":"2851_CR195","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14979","volume":"8","author":"M Ouzounova","year":"2017","unstructured":"Ouzounova, M. et al. Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade. Nat. Commun.8, 14979 (2017).","journal-title":"Nat. Commun."},{"key":"2851_CR196","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1158\/0008-5472.CAN-23-0046","volume":"83","author":"DK Nambiar","year":"2023","unstructured":"Nambiar, D. K. et al. Galectin-1 mediates chronic STING activation in tumors to promote metastasis through MDSC recruitment. Cancer Res.83, 3205\u20133219 (2023).","journal-title":"Cancer Res."},{"key":"2851_CR197","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/HEP.0000000000000773","volume":"81","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. Endothelial YAP\/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury. Hepatology81, 888\u2013902 (2025).","journal-title":"Hepatology"},{"key":"2851_CR198","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1182\/blood.2019001950","volume":"134","author":"BH Koehn","year":"2019","unstructured":"Koehn, B. H. et al. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD. Blood134, 1670\u20131682 (2019).","journal-title":"Blood"},{"key":"2851_CR199","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol.13, 159\u2013175 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR200","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41392-024-02049-y","volume":"9","author":"F Zhang","year":"2024","unstructured":"Zhang, F. et al. Neutrophil diversity and function in health and disease. Signal Transduct. Target. Ther.9, 343 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2851_CR201","doi-asserted-by":"publisher","first-page":"6826","DOI":"10.1039\/c3an01076g","volume":"138","author":"D Kim","year":"2013","unstructured":"Kim, D. & Haynes, C. L. The role of p38 MAPK in neutrophil functions: single cell chemotaxis and surface marker expression. Analyst138, 6826\u20136833 (2013).","journal-title":"Analyst"},{"key":"2851_CR202","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie, H., Gagnon, J. & Therrien, M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat. Rev. Mol. Cell Biol.21, 607\u2013632 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2851_CR203","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender, Z. G. et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u2018N1\u2019 versus \u2018N2\u2019 TAN. Cancer Cell16, 183\u2013194 (2009).","journal-title":"Cancer Cell"},{"key":"2851_CR204","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.apsb.2023.01.020","volume":"13","author":"Y-T Chan","year":"2023","unstructured":"Chan, Y.-T. et al. Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Acta Pharm. Sin. B13, 1554\u20131567 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"2851_CR205","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.ccell.2024.08.008","volume":"42","author":"M Lad","year":"2024","unstructured":"Lad, M. et al. Glioblastoma induces the recruitment and differentiation of dendritic-like \u2018hybrid\u2019 neutrophils from skull bone marrow. Cancer Cell42, 1549\u20131569.e16 (2024).","journal-title":"Cancer Cell"},{"key":"2851_CR206","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"2851_CR207","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146686","volume":"131","author":"A Ali","year":"2021","unstructured":"Ali, A. et al. Natural killer cell immunosuppressive function requires CXCR3-dependent redistribution within lymphoid tissues. J. Clin. Invest.131, e146686 (2021).","journal-title":"J. Clin. Invest."},{"key":"2851_CR208","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ni1138","volume":"5","author":"A Mart\u00edn-Fontecha","year":"2004","unstructured":"Mart\u00edn-Fontecha, A. et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol.5, 1260\u20131265 (2004).","journal-title":"Nat. Immunol."},{"key":"2851_CR209","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/eji.200535243","volume":"36","author":"C Ottaviani","year":"2006","unstructured":"Ottaviani, C. et al. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur. J. Immunol.36, 118\u2013128 (2006).","journal-title":"Eur. J. Immunol."},{"key":"2851_CR210","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.4049\/jimmunol.1601359","volume":"198","author":"G Benigni","year":"2017","unstructured":"Benigni, G. et al. CXCR3\/CXCL10 axis regulates neutrophil-NK cell cross-talk determining the severity of experimental osteoarthritis. J. Immunol.198, 2115\u20132124 (2017).","journal-title":"J. Immunol."},{"key":"2851_CR211","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","volume":"20","author":"ND Huntington","year":"2020","unstructured":"Huntington, N. D., Cursons, J. & Rautela, J. The cancer-natural killer cell immunity cycle. Nat. Rev. Cancer20, 437\u2013454 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR212","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41388-024-03211-0","volume":"44","author":"A Escoto","year":"2025","unstructured":"Escoto, A. et al. Nuclear EGFR in breast cancer suppresses NK cell recruitment and cytotoxicity. Oncogene44, 288\u2013295 (2025).","journal-title":"Oncogene"},{"key":"2851_CR213","doi-asserted-by":"publisher","first-page":"101407","DOI":"10.1016\/j.smim.2020.101407","volume":"48","author":"J Russick","year":"2020","unstructured":"Russick, J., Torset, C., Hemery, E. & Cremer, I. NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends. Semin. Immunol.48, 101407 (2020).","journal-title":"Semin. Immunol."},{"key":"2851_CR214","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fimmu.2019.00877","volume":"10","author":"C Degos","year":"2019","unstructured":"Degos, C. et al. Endometrial tumor microenvironment alters human NK cell recruitment, and resident NK cell phenotype and function. Front. Immunol.10, 877 (2019).","journal-title":"Front. Immunol."},{"key":"2851_CR215","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","volume":"78","author":"A Young","year":"2018","unstructured":"Young, A. et al. A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment. Cancer Res.78, 1003\u20131016 (2018).","journal-title":"Cancer Res."},{"key":"2851_CR216","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab.24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"2851_CR217","doi-asserted-by":"publisher","first-page":"100353","DOI":"10.1016\/j.xcrm.2021.100353","volume":"2","author":"J Qi","year":"2021","unstructured":"Qi, J. et al. Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression. Cell Rep. Med.2, 100353 (2021).","journal-title":"Cell Rep. Med."},{"key":"2851_CR218","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki, M. et al. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature638, 1076\u20131084 (2025).","journal-title":"Nature"},{"key":"2851_CR219","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni.3078","volume":"16","author":"Y Huang","year":"2015","unstructured":"Huang, Y. et al. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential \u2018inflammatory\u2019 type 2 innate lymphoid cells. Nat. Immunol.16, 161\u2013169 (2015).","journal-title":"Nat. Immunol."},{"key":"2851_CR220","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41590-021-01120-y","volume":"23","author":"M Bruchard","year":"2022","unstructured":"Bruchard, M. et al. Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Nat. Immunol.23, 262\u2013274 (2022).","journal-title":"Nat. Immunol."},{"key":"2851_CR221","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9280","volume":"6","author":"P Carrega","year":"2015","unstructured":"Carrega, P. et al. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat. Commun.6, 8280 (2015).","journal-title":"Nat. Commun."},{"key":"2851_CR222","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2017.11.020","volume":"48","author":"J Emg\u00e5rd","year":"2018","unstructured":"Emg\u00e5rd, J. et al. Oxysterol sensing through the receptor GPR183 promotes the lymphoid-tissue-inducing function of innate lymphoid cells and colonic inflammation. Immunity48, 120\u2013132.e8 (2018).","journal-title":"Immunity"},{"key":"2851_CR223","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.immuni.2021.05.007","volume":"54","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair. Immunity54, 1123\u20131136.e8 (2021).","journal-title":"Immunity"},{"key":"2851_CR224","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1094291","volume":"303","author":"WJ Nelson","year":"2004","unstructured":"Nelson, W. J. & Nusse, R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science303, 1483\u20131487 (2004).","journal-title":"Science"},{"key":"2851_CR225","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.it.2022.01.002","volume":"43","author":"KE Pauken","year":"2022","unstructured":"Pauken, K. E. et al. TCR-sequencing in cancer and autoimmunity: barcodes and beyond. Trends Immunol.43, 180\u2013194 (2022).","journal-title":"Trends Immunol."},{"key":"2851_CR226","doi-asserted-by":"crossref","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature564, 268\u2013272 (2018).","DOI":"10.1038\/s41586-018-0694-x"},{"key":"2851_CR227","doi-asserted-by":"publisher","first-page":"715552","DOI":"10.3389\/fonc.2021.715552","volume":"11","author":"W Feng","year":"2021","unstructured":"Feng, W. et al. Single-cell RNA sequencing reveals the migration of osteoclasts in giant cell tumor of bone. Front. Oncol.11, 715552 (2021).","journal-title":"Front. Oncol."},{"key":"2851_CR228","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41592-021-01201-8","volume":"18","author":"JA Pai","year":"2021","unstructured":"Pai, J. A. & Satpathy, A. T. High-throughput and single-cell T cell receptor sequencing technologies. Nat. Methods18, 881\u2013892 (2021).","journal-title":"Nat. Methods"},{"key":"2851_CR229","doi-asserted-by":"publisher","first-page":"1460442","DOI":"10.3389\/fimmu.2024.1460442","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Single-cell transcriptome atlas of peripheral immune features to Omicron breakthrough infection under booster vaccination strategies. Front. Immunol.15, 1460442 (2024).","journal-title":"Front. Immunol."},{"key":"2851_CR230","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41596-019-0290-z","volume":"15","author":"C Bramlett","year":"2020","unstructured":"Bramlett, C. et al. Clonal tracking using embedded viral barcoding and high-throughput sequencing. Nat. Protoc.15, 1436\u20131458 (2020).","journal-title":"Nat. Protoc."},{"key":"2851_CR231","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nmeth.3800","volume":"13","author":"MJT Stubbington","year":"2016","unstructured":"Stubbington, M. J. T. et al. T cell fate and clonality inference from single-cell transcriptomes. Nat. Methods13, 329\u2013332 (2016).","journal-title":"Nat. Methods"},{"key":"2851_CR232","doi-asserted-by":"publisher","first-page":"804932","DOI":"10.3389\/fimmu.2021.804932","volume":"12","author":"U Gerdemann","year":"2021","unstructured":"Gerdemann, U. et al. Identification and tracking of alloreactive t cell clones in rhesus macaques through the RM-scTCR-Seq platform. Front. Immunol.12, 804932 (2021).","journal-title":"Front. Immunol."},{"key":"2851_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48570-0","volume":"15","author":"M Ferreira-Gomes","year":"2024","unstructured":"Ferreira-Gomes, M. et al. Recruitment of plasma cells from IL-21-dependent and IL-21-independent immune reactions to the bone marrow. Nat. Commun.15, 4182 (2024).","journal-title":"Nat. Commun."},{"key":"2851_CR234","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.cellbio.22.010305.103337","volume":"22","author":"PS Kunwar","year":"2006","unstructured":"Kunwar, P. S., Siekhaus, D. E. & Lehmann, R. In vivo migration: a germ cell perspective. Annu. Rev. Cell Dev. Biol.22, 237\u2013265 (2006).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2851_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6862","volume":"6","author":"EC Mackley","year":"2015","unstructured":"Mackley, E. C. et al. CCR7-dependent trafficking of ROR\u03b3+ ILCs creates a unique microenvironment within mucosal draining lymph nodes. Nat. Commun.6, 5862 (2015).","journal-title":"Nat. Commun."},{"key":"2851_CR236","doi-asserted-by":"crossref","unstructured":"Galv\u00e1n-Pe\u00f1a, S., Zhu, Y., Hanna, B. S., Mathis, D. & Benoist, C. A dynamic atlas of immunocyte migration from the gut. Sci. Immunol. 9, eadi0672 (2024).","DOI":"10.1126\/sciimmunol.adi0672"},{"key":"2851_CR237","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/CIRCRESAHA.119.314855","volume":"125","author":"Z Ni","year":"2019","unstructured":"Ni, Z. et al. Recipient c-kit lineage cells repopulate smooth muscle cells of transplant arteriosclerosis in mouse models. Circ. Res.125, 223\u2013241 (2019).","journal-title":"Circ. Res."},{"key":"2851_CR238","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33863-z","volume":"13","author":"M Vizoso","year":"2022","unstructured":"Vizoso, M. et al. A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing. Nat. Commun.13, 6442 (2022).","journal-title":"Nat. Commun."},{"key":"2851_CR239","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nmeth.3322","volume":"12","author":"A Hasenberg","year":"2015","unstructured":"Hasenberg, A. et al. Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes. Nat. Methods12, 445\u2013452 (2015).","journal-title":"Nat. Methods"},{"key":"2851_CR240","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tcb.2015.09.003","volume":"26","author":"P Masuzzo","year":"2016","unstructured":"Masuzzo, P., Van Troys, M., Ampe, C. & Martens, L. Taking aim at moving targets in computational cell migration. Trends Cell Biol.26, 88\u2013110 (2016).","journal-title":"Trends Cell Biol."},{"key":"2851_CR241","doi-asserted-by":"crossref","unstructured":"Br\u00fcckner, D. B. & Broedersz, C. P. Learning dynamical models of single and collective cell migration: a review. Rep. Prog. Phys. Phys. Soc. G. B. 87, 056601 (2024).","DOI":"10.1088\/1361-6633\/ad36d2"},{"key":"2851_CR242","doi-asserted-by":"publisher","first-page":"113533","DOI":"10.1016\/j.bios.2021.113533","volume":"193","author":"Y Tu","year":"2021","unstructured":"Tu, Y. & Wang, X. Tracking cell migration by cellular force footprint recorded with a mechano-optical biosensor. Biosens. Bioelectron.193, 113533 (2021).","journal-title":"Biosens. Bioelectron."},{"key":"2851_CR243","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204544","volume":"10","author":"N Shao","year":"2023","unstructured":"Shao, N. et al. A bidirectional single-cell migration and retrieval chip for quantitative study of dendritic cell migration. Adv. Sci.10, e2204544 (2023).","journal-title":"Adv. Sci."},{"key":"2851_CR244","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1182\/blood-2012-06-439851","volume":"121","author":"B Vanherberghen","year":"2013","unstructured":"Vanherberghen, B. et al. Classification of human natural killer cells based on migration behavior and cytotoxic response. Blood121, 1326\u20131334 (2013).","journal-title":"Blood"},{"key":"2851_CR245","doi-asserted-by":"publisher","first-page":"106577","DOI":"10.1016\/j.compbiomed.2023.106577","volume":"154","author":"L-X Yuan","year":"2023","unstructured":"Yuan, L.-X. et al. High precision tracking analysis of cell position and motion fields using 3D U-net network models. Comput. Biol. Med.154, 106577 (2023).","journal-title":"Comput. Biol. Med."},{"key":"2851_CR246","doi-asserted-by":"publisher","first-page":"102358","DOI":"10.1016\/j.media.2022.102358","volume":"77","author":"M Molina-Moreno","year":"2022","unstructured":"Molina-Moreno, M. et al. ACME: automatic feature extraction for cell migration examination through intravital microscopy imaging. Med. Image Anal.77, 102358 (2022).","journal-title":"Med. Image Anal."},{"key":"2851_CR247","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201907966","volume":"32","author":"P Samal","year":"2020","unstructured":"Samal, P., Maurer, P., van Blitterswijk, C., Truckenm\u00fcller, R. & Giselbrecht, S. A new microengineered platform for 4D tracking of single cells in a stem-cell-based in vitro morphogenesis model. Adv. Mater.32, e1907966 (2020).","journal-title":"Adv. Mater."},{"key":"2851_CR248","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/wnan.1227","volume":"5","author":"GA Dekaban","year":"2013","unstructured":"Dekaban, G. A. et al. Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.5, 469\u2013483 (2013).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"2851_CR249","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1021\/acs.bioconjchem.7b00194","volume":"28","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. Use of nanoparticle contrast agents for cell tracking with computed tomography. Bioconjug. Chem.28, 1581\u20131597 (2017).","journal-title":"Bioconjug. Chem."},{"key":"2851_CR250","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202301673","volume":"19","author":"I Kim","year":"2023","unstructured":"Kim, I. et al. Real-time, in situ imaging of macrophages via phase-change peptide nanoemulsions. Small19, e2301673 (2023).","journal-title":"Small"},{"key":"2851_CR251","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1021\/acsnano.5b01939","volume":"9","author":"R Meir","year":"2015","unstructured":"Meir, R. et al. Nanomedicine for cancer immunotherapy: tracking cancer-specific T-cells in vivo with gold nanoparticles and CT imaging. ACS Nano9, 6363\u20136372 (2015).","journal-title":"ACS Nano"},{"key":"2851_CR252","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nri3531","volume":"13","author":"ET Ahrens","year":"2013","unstructured":"Ahrens, E. T. & Bulte, J. W. M. Tracking immune cells in vivo using magnetic resonance imaging. Nat. Rev. Immunol.13, 755\u2013763 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR253","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biomaterials.2015.04.016","volume":"58","author":"Y Xu","year":"2015","unstructured":"Xu, Y. et al. Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner. Biomaterials58, 63\u201371 (2015).","journal-title":"Biomaterials"},{"key":"2851_CR254","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00924-2","volume":"19","author":"D Lu","year":"2021","unstructured":"Lu, D. et al. Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy. J. Nanobiotechnology19, 175 (2021).","journal-title":"J. Nanobiotechnology"},{"key":"2851_CR255","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1172\/JCI77326","volume":"125","author":"MN McCracken","year":"2015","unstructured":"McCracken, M. N. et al. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging. J. Clin. Invest.125, 1815\u20131826 (2015).","journal-title":"J. Clin. Invest."},{"key":"2851_CR256","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/nm.1971","volume":"15","author":"BJ Vakoc","year":"2009","unstructured":"Vakoc, B. J. et al. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat. Med.15, 1219\u20131223 (2009).","journal-title":"Nat. Med."},{"key":"2851_CR257","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.1021\/acsnano.9b02656","volume":"13","author":"ED SoRelle","year":"2019","unstructured":"SoRelle, E. D. et al. Spatiotemporal tracking of brain-tumor-associated myeloid cells in vivo through optical coherence tomography with plasmonic labeling and speckle modulation. ACS Nano13, 7985\u20137995 (2019).","journal-title":"ACS Nano"},{"key":"2851_CR258","doi-asserted-by":"publisher","first-page":"13289","DOI":"10.1021\/acsnano.1c03035","volume":"15","author":"VP Nguyen","year":"2021","unstructured":"Nguyen, V. P. et al. Long-term, noninvasive in vivo tracking of progenitor cells using multimodality photoacoustic, optical coherence tomography, and fluorescence imaging. ACS Nano15, 13289\u201313306 (2021).","journal-title":"ACS Nano"},{"key":"2851_CR259","doi-asserted-by":"publisher","first-page":"11075","DOI":"10.1021\/jacs.2c02962","volume":"144","author":"H Fukushima","year":"2022","unstructured":"Fukushima, H. et al. Cyanine phototruncation enables spatiotemporal cell labeling. J. Am. Chem. Soc.144, 11075\u201311080 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"2851_CR260","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105050","volume":"102","author":"H Fukushima","year":"2024","unstructured":"Fukushima, H. et al. Phototruncation cell tracking with near-infrared photoimmunotherapy using heptamethine cyanine dye to visualise migratory dynamics of immune cells. EBioMedicine102, 105050 (2024).","journal-title":"EBioMedicine"},{"key":"2851_CR261","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.aaq1067","volume":"359","author":"S Iwano","year":"2018","unstructured":"Iwano, S. et al. Single-cell bioluminescence imaging of deep tissue in freely moving animals. Science359, 935\u2013939 (2018).","journal-title":"Science"},{"key":"2851_CR262","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cac2.12539","volume":"44","author":"G-R Khosravi","year":"2024","unstructured":"Khosravi, G.-R. et al. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Commun.44, 521\u2013553 (2024).","journal-title":"Cancer Commun."},{"key":"2851_CR263","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","volume":"22","author":"NK Bj\u00f6rkstr\u00f6m","year":"2022","unstructured":"Bj\u00f6rkstr\u00f6m, N. K., Strunz, B. & Ljunggren, H.-G. Natural killer cells in antiviral immunity. Nat. Rev. Immunol.22, 112\u2013123 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR264","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41573-024-00959-8","volume":"23","author":"F Ram\u00edrez-Valle","year":"2024","unstructured":"Ram\u00edrez-Valle, F., Maranville, J. C., Roy, S. & Plenge, R. M. Sequential immunotherapy: towards cures for autoimmunity. Nat. Rev. Drug Discov.23, 501\u2013524 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2851_CR265","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","volume":"49","author":"J Li","year":"2018","unstructured":"Li, J. et al. Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy. Immunity49, 178\u2013193.e7 (2018).","journal-title":"Immunity"},{"key":"2851_CR266","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","volume":"256","author":"D Raman","year":"2007","unstructured":"Raman, D., Baugher, P. J., Thu, Y. M. & Richmond, A. Role of chemokines in tumor growth. Cancer Lett.256, 137\u2013165 (2007).","journal-title":"Cancer Lett."},{"key":"2851_CR267","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1158\/0008-5472.CAN-16-2913","volume":"77","author":"Y Ban","year":"2017","unstructured":"Ban, Y. et al. Targeting autocrine CCL5-CCR5 axis reprograms immunosuppressive myeloid cells and reinvigorates antitumor immunity. Cancer Res.77, 2857\u20132868 (2017).","journal-title":"Cancer Res."},{"key":"2851_CR268","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.955691","volume":"3","author":"O Kepp","year":"2014","unstructured":"Kepp, O. et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology3, e955691 (2014).","journal-title":"Oncoimmunology"},{"key":"2851_CR269","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337","volume":"8","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi, L. et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J. Immunother. Cancer8, e000337 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"2851_CR270","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ccell.2022.08.016","volume":"40","author":"JK Mandula","year":"2022","unstructured":"Mandula, J. K. et al. Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses. Cancer Cell40, 1145\u20131160.e9 (2022).","journal-title":"Cancer Cell"},{"key":"2851_CR271","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.add2282","volume":"16","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. STAT3 palmitoylation initiates a positive feedback loop that promotes the malignancy of hepatocellular carcinoma cells in mice. Sci. Signal.16, eadd2282 (2023).","journal-title":"Sci. Signal."},{"key":"2851_CR272","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/gutjnl-2019-319200","volume":"69","author":"C Heichler","year":"2020","unstructured":"Heichler, C. et al. STAT3 activation through IL-6\/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis. Gut.69, 1269\u20131282 (2020).","journal-title":"Gut."},{"key":"2851_CR273","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2006.10.010","volume":"132","author":"M Sans","year":"2007","unstructured":"Sans, M. et al. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. Gastroenterology132, 139\u2013153 (2007).","journal-title":"Gastroenterology"},{"key":"2851_CR274","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adk2612","volume":"9","author":"R Zhao","year":"2024","unstructured":"Zhao, R. et al. cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation. Sci. Immunol.9, eadk2612 (2024).","journal-title":"Sci. Immunol."},{"key":"2851_CR275","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/cmi.2016.47","volume":"14","author":"L-D Zhao","year":"2017","unstructured":"Zhao, L.-D. et al. Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus. Cell. Mol. Immunol.14, 842\u2013849 (2017).","journal-title":"Cell. Mol. Immunol."},{"key":"2851_CR276","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jaci.2011.07.051","volume":"129","author":"S Provoost","year":"2012","unstructured":"Provoost, S., Maes, T., Joos, G. F. & Tournoy, K. G. Monocyte-derived dendritic cell recruitment and allergic T(H)2 responses after exposure to diesel particles are CCR2 dependent. J. Allergy Clin. Immunol.129, 483\u2013491 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2851_CR277","doi-asserted-by":"publisher","first-page":"2202226","DOI":"10.1183\/13993003.02226-2022","volume":"61","author":"NA Scott","year":"2023","unstructured":"Scott, N. A. et al. Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID. Eur. Respir. J.61, 2202226 (2023).","journal-title":"Eur. Respir. J."},{"key":"2851_CR278","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s42255-022-00525-9","volume":"4","author":"S Maqdasy","year":"2022","unstructured":"Maqdasy, S. et al. Impaired phosphocreatine metabolism in white adipocytes promotes inflammation. Nat. Metab.4, 190\u2013202 (2022).","journal-title":"Nat. Metab."},{"key":"2851_CR279","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41423-019-0262-9","volume":"17","author":"T-Y Lin","year":"2020","unstructured":"Lin, T.-Y. et al. IL-29 promoted obesity-induced inflammation and insulin resistance. Cell. Mol. Immunol.17, 369\u2013379 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"2851_CR280","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/hep.30525","volume":"69","author":"S-J Kim","year":"2019","unstructured":"Kim, S.-J. et al. Adipocyte death preferentially induces liver injury and inflammation through the activation of chemokine (C-C Motif) receptor 2-positive macrophages and lipolysis. Hepatology69, 1965\u20131982 (2019).","journal-title":"Hepatology"},{"key":"2851_CR281","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13046-020-01666-z","volume":"39","author":"C Zhao","year":"2020","unstructured":"Zhao, C. et al. Cancer-associated adipocytes: emerging supporters in breast cancer. J. Exp. Clin. Cancer Res.39, 156 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2851_CR282","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06230-z","volume":"14","author":"R Huang","year":"2023","unstructured":"Huang, R. et al. Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy. Cell Death Dis.14, 703 (2023).","journal-title":"Cell Death Dis."},{"key":"2851_CR283","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","volume":"601","author":"Z Xu","year":"2022","unstructured":"Xu, Z. et al. Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature601, 118\u2013124 (2022).","journal-title":"Nature"},{"key":"2851_CR284","doi-asserted-by":"publisher","DOI":"10.1172\/JCI182709","volume":"135","author":"Y Yamamura","year":"2025","unstructured":"Yamamura, Y. et al. CXCL12+ fibroblastic reticular cells in lymph nodes facilitate immune tolerance by regulating T cell-mediated alloimmunity. J. Clin. Invest.135, e182709 (2025).","journal-title":"J. Clin. Invest."},{"key":"2851_CR285","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/eji.202048681","volume":"51","author":"S Umar","year":"2021","unstructured":"Umar, S. et al. CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts. Eur. J. Immunol.51, 903\u2013914 (2021).","journal-title":"Eur. J. Immunol."},{"key":"2851_CR286","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med.204, 2803\u20132812 (2007).","journal-title":"J. Exp. Med."},{"key":"2851_CR287","doi-asserted-by":"publisher","first-page":"28960","DOI":"10.1073\/pnas.2013644117","volume":"117","author":"D Biasci","year":"2020","unstructured":"Biasci, D. et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc. Natl. Acad. Sci. USA.117, 28960\u201328970 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2851_CR288","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.coi.2017.03.001","volume":"45","author":"AE Denton","year":"2017","unstructured":"Denton, A. E. & Linterman, M. A. Stromal networking: cellular connections in the germinal centre. Curr. Opin. Immunol.45, 103\u2013111 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"2851_CR289","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14293-1","volume":"11","author":"SY Choi","year":"2020","unstructured":"Choi, S. Y. et al. YAP\/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells. Nat. Commun.11, 519 (2020).","journal-title":"Nat. Commun."},{"key":"2851_CR290","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","volume":"188","author":"L Onder","year":"2025","unstructured":"Onder, L. et al. Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer. Cell188, 430\u2013446.e20 (2025).","journal-title":"Cell"},{"key":"2851_CR291","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-020-00897-z","volume":"13","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A\/STAT3 in advanced-stage colorectal cancer patients. J. Hematol. Oncol. J. Hematol. Oncol.13, 68 (2020).","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"2851_CR292","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1084\/jem.20170277","volume":"216","author":"M Rapp","year":"2019","unstructured":"Rapp, M. et al. CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. J. Exp. Med.216, 1170\u20131181 (2019).","journal-title":"J. Exp. Med."},{"key":"2851_CR293","doi-asserted-by":"crossref","unstructured":"La, M. et al. Tumors establish resistance to immunotherapy by regulating Treg recruitment via CCR4. J. Immunother. Cancer8, e000764 (2020).","DOI":"10.1136\/jitc-2020-000764"},{"key":"2851_CR294","doi-asserted-by":"crossref","unstructured":"Ma, J. et al. Lysosome blockade induces divergent metabolic programs in macrophages and tumours for cancer immunotherapy. J. Exp. Clin. Cancer Res.42, 192 (2023).","DOI":"10.1186\/s13046-023-02768-0"},{"key":"2851_CR295","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.ccell.2023.06.008","volume":"41","author":"P Meiser","year":"2023","unstructured":"Meiser, P. et al. A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity. Cancer Cell41, 1498\u20131515.e10 (2023).","journal-title":"Cancer Cell"},{"key":"2851_CR296","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger, S., Dai, D., Horton, B. & Gajewski, T. F. Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell31, 711\u2013723.e4 (2017).","journal-title":"Cancer Cell"},{"key":"2851_CR297","doi-asserted-by":"publisher","first-page":"101280","DOI":"10.1016\/j.smim.2019.05.002","volume":"43","author":"JD Burke","year":"2019","unstructured":"Burke, J. D. & Young, H. A. IFN-\u03b3: a cytokine at the right time, is in the right place. Semin. Immunol.43, 101280 (2019).","journal-title":"Semin. Immunol."},{"key":"2851_CR298","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic, D., Song, M., Wang, L. & Zhang, Y. Roles of IFN-\u03b3 in tumor progression and regression: a review. Biomark. Res.8, 49 (2020).","journal-title":"Biomark. Res."},{"key":"2851_CR299","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","volume":"185","author":"P Baldominos","year":"2022","unstructured":"Baldominos, P. et al. Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell185, 1694\u20131708.e19 (2022).","journal-title":"Cell"},{"key":"2851_CR300","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000870","volume":"10","author":"S Sato","year":"2023","unstructured":"Sato, S. et al. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL\/lpr mouse. Lupus Sci. Med.10, e000870 (2023).","journal-title":"Lupus Sci. Med."},{"key":"2851_CR301","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.jaci.2012.01.052","volume":"129","author":"M Crapster-Pregont","year":"2012","unstructured":"Crapster-Pregont, M., Yeo, J., Sanchez, R. L. & Kuperman, D. A. Dendritic cells and alveolar macrophages mediate IL-13-induced airway inflammation and chemokine production. J. Allergy Clin. Immunol.129, 1621\u20131627.e3 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"2851_CR302","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41423-024-01199-x","volume":"21","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20\/CCR6 axis in human hepatocellular carcinoma. Cell. Mol. Immunol.21, 1120\u20131130 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"2851_CR303","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/cr.2017.34","volume":"27","author":"S Su","year":"2017","unstructured":"Su, S. et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res.27, 461\u2013482 (2017).","journal-title":"Cell Res."},{"key":"2851_CR304","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House, I. G. et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin. Cancer Res.26, 487\u2013504 (2020).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR305","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.4049\/jimmunol.1000900","volume":"185","author":"SL Ellis","year":"2010","unstructured":"Ellis, S. L. et al. The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1. J. Immunol.185, 1864\u20131877 (2010).","journal-title":"J. Immunol."},{"key":"2851_CR306","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.15252\/emmm.201404144","volume":"6","author":"J Diana","year":"2014","unstructured":"Diana, J. & Lehuen, A. Macrophages and \u03b2-cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes. EMBO Mol. Med.6, 1090\u20131104 (2014).","journal-title":"EMBO Mol. Med."},{"key":"2851_CR307","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.2337\/db14-0480","volume":"63","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with \u03b2-cell autoimmunity in patients with type 1 diabetes. Diabetes63, 4239\u20134248 (2014).","journal-title":"Diabetes"},{"key":"2851_CR308","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaj2195","volume":"2","author":"Y Miyabe","year":"2017","unstructured":"Miyabe, Y. et al. Complement C5a receptor is the key initiator of neutrophil adhesion igniting immune complex-induced arthritis. Sci. Immunol.2, eaaj2195 (2017).","journal-title":"Sci. Immunol."},{"key":"2851_CR309","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12175","volume":"498","author":"T L\u00e4mmermann","year":"2013","unstructured":"L\u00e4mmermann, T. et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature498, 371\u2013375 (2013).","journal-title":"Nature"},{"key":"2851_CR310","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe7729","volume":"372","author":"K Kienle","year":"2021","unstructured":"Kienle, K. et al. Neutrophils self-limit swarming to contain bacterial growth in vivo. Science372, eabe7729 (2021).","journal-title":"Science"},{"key":"2851_CR311","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","volume":"150","author":"S-L Zhou","year":"2016","unstructured":"Zhou, S.-L. et al. Tumor-associated neutrophils recruit macrophages and t-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib. Gastroenterology150, 1646\u20131658.e17 (2016).","journal-title":"Gastroenterology"},{"key":"2851_CR312","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1158\/2326-6066.CIR-20-0839","volume":"9","author":"ME Shaul","year":"2021","unstructured":"Shaul, M. E. et al. Tumor-associated neutrophils drive B-cell recruitment and their differentiation to plasma cells. Cancer Immunol. Res.9, 811\u2013824 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"2851_CR313","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum, D. C. & June, C. H. Cytokine storm. N. Engl. J. Med.383, 2255\u20132273 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2851_CR314","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-025-02178-y","volume":"10","author":"J Nie","year":"2025","unstructured":"Nie, J. et al. Deep insight into cytokine storm: from pathogenesis to treatment. Signal Transduct. Target. Ther.10, 112 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2851_CR315","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1126\/science.aaa8064","volume":"349","author":"A Warnatsch","year":"2015","unstructured":"Warnatsch, A., Ioannou, M., Wang, Q. & Papayannopoulos, V. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science349, 316\u2013320 (2015).","journal-title":"Science"},{"key":"2851_CR316","doi-asserted-by":"publisher","first-page":"112147","DOI":"10.1016\/j.celrep.2023.112147","volume":"42","author":"JT Clark","year":"2023","unstructured":"Clark, J. T. et al. IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii. Cell Rep.42, 112147 (2023).","journal-title":"Cell Rep."},{"key":"2851_CR317","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20140964","volume":"212","author":"MR Jenkins","year":"2015","unstructured":"Jenkins, M. R. et al. Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J. Exp. Med.212, 307\u2013317 (2015).","journal-title":"J. Exp. Med."},{"key":"2851_CR318","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042921-112837","volume":"74","author":"RQ Cron","year":"2023","unstructured":"Cron, R. Q., Goyal, G. & Chatham, W. W. Cytokine storm syndrome. Annu. Rev. Med.74, 321\u2013337 (2023).","journal-title":"Annu. Rev. Med."},{"key":"2851_CR319","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/ijms19020485","volume":"19","author":"A Bertoni","year":"2018","unstructured":"Bertoni, A., Alabiso, O., Galetto, A. S. & Baldanzi, G. Integrins in T cell physiology. Int. J. Mol. Sci.19, 485 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"2851_CR320","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/j.immuni.2024.09.003","volume":"57","author":"JM Messmer","year":"2024","unstructured":"Messmer, J. M. et al. T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels. Immunity57, 2688\u20132703.e11 (2024).","journal-title":"Immunity"},{"key":"2851_CR321","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj0473","volume":"14","author":"M Charabati","year":"2022","unstructured":"Charabati, M. et al. DICAM promotes TH17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation. Sci. Transl. Med.14, eabj0473 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2851_CR322","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.immuni.2021.07.012","volume":"54","author":"N Reglero-Real","year":"2021","unstructured":"Reglero-Real, N. et al. Autophagy modulates endothelial junctions to restrain neutrophil diapedesis during inflammation. Immunity54, 1989\u20132004.e9 (2021).","journal-title":"Immunity"},{"key":"2851_CR323","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.molmed.2019.02.010","volume":"25","author":"G Hajishengallis","year":"2019","unstructured":"Hajishengallis, G. & Chavakis, T. DEL-1-Regulated immune plasticity and inflammatory disorders. Trends Mol. Med.25, 444\u2013459 (2019).","journal-title":"Trends Mol. Med."},{"key":"2851_CR324","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s11658-021-00274-9","volume":"26","author":"M Li","year":"2021","unstructured":"Li, M., Zhong, D. & Li, G. Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review. Cell. Mol. Biol. Lett.26, 31 (2021).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"2851_CR325","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1158\/2326-6066.CIR-23-0171","volume":"11","author":"S Tabasum","year":"2023","unstructured":"Tabasum, S. et al. EDIL3 as an angiogenic target of immune exclusion following checkpoint blockade. Cancer Immunol. Res.11, 1493\u20131507 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"2851_CR326","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma. J. Exp. Clin. Cancer Res.43, 252 (2024).","DOI":"10.1186\/s13046-024-03175-9"},{"key":"2851_CR327","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","volume":"68","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y. et al. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut.68, 1653\u20131666 (2019).","journal-title":"Gut."},{"key":"2851_CR328","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00014.2023","volume":"105","author":"DE Rassier","year":"2025","unstructured":"Rassier, D. E. & M\u00e5nsson, A. Mechanisms of myosin II force generation: insights from novel experimental techniques and approaches. Physiol. Rev.105, 1\u201393 (2025).","journal-title":"Physiol. Rev."},{"key":"2851_CR329","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2018.12.038","volume":"176","author":"M Georgouli","year":"2019","unstructured":"Georgouli, M. et al. Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment. Cell176, 757\u2013774.e23 (2019).","journal-title":"Cell"},{"key":"2851_CR330","doi-asserted-by":"crossref","unstructured":"Chen, H. et al. METTL3 inhibits antitumor immunity by targeting m6A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer. Gastroenterology163, 891\u2013907 (2022).","DOI":"10.1053\/j.gastro.2022.06.024"},{"key":"2851_CR331","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar, M. A. et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct. Target. Ther.9, 27 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2851_CR332","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.immuni.2024.07.009","volume":"57","author":"R Kalluri","year":"2024","unstructured":"Kalluri, R. The biology and function of extracellular vesicles in immune response and immunity. Immunity57, 1752\u20131768 (2024).","journal-title":"Immunity"},{"key":"2851_CR333","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23946-8","volume":"12","author":"LG Lima","year":"2021","unstructured":"Lima, L. G. et al. Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution. Nat. Commun.12, 3543 (2021).","journal-title":"Nat. Commun."},{"key":"2851_CR334","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik, D. L., Colli, M. L. & Ortis, F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol.5, 219\u2013226 (2009).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2851_CR335","doi-asserted-by":"publisher","first-page":"109613","DOI":"10.1016\/j.celrep.2021.109613","volume":"36","author":"N Javeed","year":"2021","unstructured":"Javeed, N. et al. Pro-inflammatory \u03b2 cell small extracellular vesicles induce \u03b2 cell failure through activation of the CXCL10\/CXCR3 axis in diabetes. Cell Rep.36, 109613 (2021).","journal-title":"Cell Rep."},{"key":"2851_CR336","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jhep.2019.07.019","volume":"71","author":"Q Guo","year":"2019","unstructured":"Guo, Q. et al. Integrin \u03b21-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. J. Hepatol.71, 1193\u20131205 (2019).","journal-title":"J. Hepatol."},{"key":"2851_CR337","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrrheum.2014.19","volume":"10","author":"EI Buzas","year":"2014","unstructured":"Buzas, E. I., Gy\u00f6rgy, B., Nagy, G., Falus, A. & Gay, S. Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol.10, 356\u2013364 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2851_CR338","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B. et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol.17, 816\u2013826 (2015).","journal-title":"Nat. Cell Biol."},{"key":"2851_CR339","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13054-021-03775-3","volume":"25","author":"Y Jiao","year":"2021","unstructured":"Jiao, Y. et al. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury. Crit. Care25, 356 (2021).","journal-title":"Crit. Care"},{"key":"2851_CR340","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","volume":"6","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. Exosomes released from tumor-associated macrophages transfer miRNAs that induce a Treg\/Th17 cell imbalance in epithelial ovarian cancer. Cancer Immunol. Res.6, 1578\u20131592 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"2851_CR341","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment. Cell Metab.35, 1209\u20131226.e13 (2023).","journal-title":"Cell Metab."},{"key":"2851_CR342","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1158\/2326-6066.CIR-19-0449","volume":"8","author":"E Wennerberg","year":"2020","unstructured":"Wennerberg, E. et al. CD73 blockade promotes dendritic cell infiltration of irradiated tumors and tumor rejection. Cancer Immunol. Res.8, 465\u2013478 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"2851_CR343","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.apsb.2022.10.027","volume":"13","author":"M Zheng","year":"2023","unstructured":"Zheng, M. et al. The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy. Acta Pharm. Sin. B13, 1488\u20131497 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"2851_CR344","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bbalip.2017.07.006","volume":"1862","author":"MA Welte","year":"2017","unstructured":"Welte, M. A. & Gould, A. P. Lipid droplet functions beyond energy storage. Biochim. Biophys. Acta Mol. Cell Biol. Lipids1862, 1260\u20131272 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"2851_CR345","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53706-3","volume":"15","author":"S Punyawatthananukool","year":"2024","unstructured":"Punyawatthananukool, S. et al. Prostaglandin E2-EP2\/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells. Nat. Commun.15, 9464 (2024).","journal-title":"Nat. Commun."},{"key":"2851_CR346","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1124\/pharmrev.123.000901","volume":"76","author":"A Santiso","year":"2024","unstructured":"Santiso, A., Heinemann, A. & Kargl, J. Prostaglandin E2 in the tumor microenvironment, a convoluted affair mediated by EP receptors 2 and 4. Pharmacol. Rev.76, 388\u2013413 (2024).","journal-title":"Pharmacol. Rev."},{"key":"2851_CR347","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1038\/s42255-024-01149-x","volume":"6","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling. Nat. Metab.6, 2118\u20132137 (2024).","journal-title":"Nat. Metab."},{"key":"2851_CR348","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11738-0","volume":"10","author":"Z Xiao","year":"2019","unstructured":"Xiao, Z., Dai, Z. & Locasale, J. W. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat. Commun.10, 3763 (2019).","journal-title":"Nat. Commun."},{"key":"2851_CR349","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","volume":"25","author":"B Kelly","year":"2015","unstructured":"Kelly, B. & O\u2019Neill, L. A. J. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res.25, 771\u2013784 (2015).","journal-title":"Cell Res."},{"key":"2851_CR350","doi-asserted-by":"publisher","first-page":"894853","DOI":"10.3389\/fimmu.2023.894853","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma. Front. Immunol.14, 894853 (2023).","journal-title":"Front. Immunol."},{"key":"2851_CR351","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002202","volume":"13","author":"R Haas","year":"2015","unstructured":"Haas, R. et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol.13, e1002202 (2015).","journal-title":"PLoS Biol."},{"key":"2851_CR352","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13046-024-03025-8","volume":"43","author":"C Yan","year":"2024","unstructured":"Yan, C. et al. GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP\/PKA\/CREB pathway to promote glioma progression. J. Exp. Clin. Cancer Res.43, 105 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2851_CR353","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41423-018-0001-7","volume":"15","author":"E Mohamed","year":"2018","unstructured":"Mohamed, E., Al-Khami, A. A. & Rodriguez, P. C. The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates. Cell. Mol. Immunol.15, 421\u2013427 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"2851_CR354","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccell.2016.06.025","volume":"30","author":"A Young","year":"2016","unstructured":"Young, A. et al. Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses. Cancer Cell30, 391\u2013403 (2016).","journal-title":"Cancer Cell"},{"key":"2851_CR355","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1653","volume":"9","author":"MS Woo","year":"2023","unstructured":"Woo, M. S. et al. Calcium channel \u03b23 subunit regulates ATP-dependent migration of dendritic cells. Sci. Adv.9, eadh1653 (2023).","journal-title":"Sci. Adv."},{"key":"2851_CR356","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrc3726","volume":"14","author":"DM Gilkes","year":"2014","unstructured":"Gilkes, D. M., Semenza, G. L. & Wirtz, D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat. Rev. Cancer14, 430\u2013439 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR357","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1158\/0008-5472.CAN-14-2598","volume":"74","author":"IB Barsoum","year":"2014","unstructured":"Barsoum, I. B., Koti, M., Siemens, D. R. & Graham, C. H. Mechanisms of hypoxia-mediated immune escape in cancer. Cancer Res.74, 7185\u20137190 (2014).","journal-title":"Cancer Res."},{"key":"2851_CR358","doi-asserted-by":"crossref","unstructured":"As, M., Ma, S.-G. & Sr, W. How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia. Nat. Rev. Immunol. 25, 161\u2013177 (2025).","DOI":"10.1038\/s41577-024-01087-5"},{"key":"2851_CR359","doi-asserted-by":"crossref","unstructured":"El, C. et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity40, 66\u201377 (2014).","DOI":"10.1016\/j.immuni.2013.11.020"},{"key":"2851_CR360","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","volume":"56","author":"A Sattiraju","year":"2023","unstructured":"Sattiraju, A. et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity56, 1825\u20131843.e6 (2023).","journal-title":"Immunity"},{"key":"2851_CR361","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3389\/fimmu.2018.02358","volume":"9","author":"M Parodi","year":"2018","unstructured":"Parodi, M. et al. Hypoxia modifies the transcriptome of human NK cells, modulates their immunoregulatory profile, and influences NK cell subset migration. Front. Immunol.9, 2358 (2018).","journal-title":"Front. Immunol."},{"key":"2851_CR362","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41586-019-1087-5","volume":"568","author":"J Renkawitz","year":"2019","unstructured":"Renkawitz, J. et al. Nuclear positioning facilitates amoeboid migration along the path of least resistance. Nature568, 546\u2013550 (2019).","journal-title":"Nature"},{"key":"2851_CR363","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI45817","volume":"122","author":"H Salmon","year":"2012","unstructured":"Salmon, H. et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J. Clin. Invest.122, 899\u2013910 (2012).","journal-title":"J. Clin. Invest."},{"key":"2851_CR364","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41590-024-01856-3","volume":"25","author":"Z Alraies","year":"2024","unstructured":"Alraies, Z. et al. Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodes. Nat. Immunol.25, 1193\u20131206 (2024).","journal-title":"Nat. Immunol."},{"key":"2851_CR365","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav7638","volume":"4","author":"F Puttur","year":"2019","unstructured":"Puttur, F. et al. Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans. Sci. Immunol.4, eaav7638 (2019).","journal-title":"Sci. Immunol."},{"key":"2851_CR366","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3389\/fimmu.2020.01501","volume":"11","author":"NRJ Fernandes","year":"2020","unstructured":"Fernandes, N. R. J. et al. CD4+ T cell interstitial migration controlled by fibronectin in the inflamed skin. Front. Immunol.11, 1501 (2020).","journal-title":"Front. Immunol."},{"key":"2851_CR367","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/science.1228456","volume":"339","author":"M Weber","year":"2013","unstructured":"Weber, M. et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science339, 328\u2013332 (2013).","journal-title":"Science"},{"key":"2851_CR368","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adf2537","volume":"16","author":"AJL Ridley","year":"2023","unstructured":"Ridley, A. J. L. et al. Chemokines form complex signals during inflammation and disease that can be decoded by extracellular matrix proteoglycans. Sci. Signal.16, eadf2537 (2023).","journal-title":"Sci. Signal."},{"key":"2851_CR369","doi-asserted-by":"publisher","first-page":"114319","DOI":"10.1016\/j.addr.2022.114319","volume":"186","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy. Adv. Drug Deliv. Rev.186, 114319 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2851_CR370","doi-asserted-by":"publisher","first-page":"eabp8964","DOI":"10.1126\/science.abp8964","volume":"379","author":"TE Sutherland","year":"2023","unstructured":"Sutherland, T. E., Dyer, D. P. & Allen, J. E. The extracellular matrix and the immune system: a mutually dependent relationship. Science379, eabp8964 (2023).","journal-title":"Science"},{"key":"2851_CR371","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1074\/jbc.RA119.011916","volume":"295","author":"DC Briggs","year":"2020","unstructured":"Briggs, D. C. et al. Inter-\u03b1-inhibitor heavy chain-1 has an integrin-like 3D structure mediating immune regulatory activities and matrix stabilization during ovulation. J. Biol. Chem.295, 5278\u20135291 (2020).","journal-title":"J. Biol. Chem."},{"key":"2851_CR372","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.matbio.2018.01.011","volume":"78\u201379","author":"AJ Day","year":"2019","unstructured":"Day, A. J. & Milner, C. M. TSG-6: a multifunctional protein with anti-inflammatory and tissue-protective properties. Matrix Biol.78\u201379, 60\u201383 (2019).","journal-title":"Matrix Biol."},{"key":"2851_CR373","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1165\/rcmb.2015-0358OC","volume":"55","author":"B Matuska","year":"2016","unstructured":"Matuska, B. et al. Pathological hyaluronan matrices in cystic fibrosis airways and secretions. Am. J. Respir. Cell Mol. Biol.55, 576\u2013585 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2851_CR374","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12931-018-0849-1","volume":"19","author":"SR Reeves","year":"2018","unstructured":"Reeves, S. R. et al. Asthmatic bronchial epithelial cells promote the establishment of a Hyaluronan-enriched, leukocyte-adhesive extracellular matrix by lung fibroblasts. Respir. Res.19, 146 (2018).","journal-title":"Respir. Res."},{"key":"2851_CR375","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.58688","volume":"10","author":"A Nicolas-Boluda","year":"2021","unstructured":"Nicolas-Boluda, A. et al. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. eLife10, e58688 (2021).","journal-title":"eLife"},{"key":"2851_CR376","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","volume":"54","author":"AJ Ozga","year":"2021","unstructured":"Ozga, A. J., Chow, M. T. & Luster, A. D. Chemokines and the immune response to cancer. Immunity54, 859\u2013874 (2021).","journal-title":"Immunity"},{"key":"2851_CR377","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39762-1","volume":"14","author":"L Cords","year":"2023","unstructured":"Cords, L. et al. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat. Commun.14, 4294 (2023).","journal-title":"Nat. Commun."},{"key":"2851_CR378","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","volume":"24","author":"L Arpinati","year":"2024","unstructured":"Arpinati, L., Carradori, G. & Scherz-Shouval, R. CAF-induced physical constraints controlling T cell state and localization in solid tumours. Nat. Rev. Cancer24, 676\u2013693 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR379","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce, J. A. & Fearon, D. T. T cell exclusion, immune privilege, and the tumor microenvironment. Science348, 74\u201380 (2015).","journal-title":"Science"},{"key":"2851_CR380","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature500, 232\u2013236 (2013).","journal-title":"Nature"},{"key":"2851_CR381","doi-asserted-by":"crossref","unstructured":"Zhou, W. et al. ILC3s sense gut microbiota through STING to initiate immune tolerance. Immunity58, 1762\u20131777 (2025).","DOI":"10.1016\/j.immuni.2025.05.016"},{"key":"2851_CR382","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo2296","volume":"380","author":"M Fidelle","year":"2023","unstructured":"Fidelle, M. et al. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Science380, eabo2296 (2023).","journal-title":"Science"},{"key":"2851_CR383","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53347-6","volume":"15","author":"WS Lee","year":"2024","unstructured":"Lee, W. S. et al. Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer. Nat. Commun.15, 9092 (2024).","journal-title":"Nat. Commun."},{"key":"2851_CR384","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/microorganisms9010034","volume":"9","author":"JE Mindur","year":"2020","unstructured":"Mindur, J. E. et al. Surface layer protein a expressed in clostridioides difficile DJNS06-36 possesses an encephalitogenic mimotope of myelin basic protein. Microorganisms9, 34 (2020).","journal-title":"Microorganisms"},{"key":"2851_CR385","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41590-025-02125-7","volume":"26","author":"T Fan","year":"2025","unstructured":"Fan, T. et al. Aberrant T follicular helper cells generated by TH17 cell plasticity in the gut promote extraintestinal autoimmunity. Nat. Immunol.26, 790\u2013804 (2025).","journal-title":"Nat. Immunol."},{"key":"2851_CR386","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.chom.2021.09.010","volume":"29","author":"V Woo","year":"2021","unstructured":"Woo, V. et al. Commensal segmented filamentous bacteria-derived retinoic acid primes host defense to intestinal infection. Cell Host Microbe29, 1744\u20131756.e5 (2021).","journal-title":"Cell Host Microbe"},{"key":"2851_CR387","doi-asserted-by":"publisher","first-page":"113005","DOI":"10.1016\/j.celrep.2023.113005","volume":"42","author":"K Miyamoto","year":"2023","unstructured":"Miyamoto, K. et al. The gut microbiota-induced kynurenic acid recruits GPR35-positive macrophages to promote experimental encephalitis. Cell Rep.42, 113005 (2023).","journal-title":"Cell Rep."},{"key":"2851_CR388","doi-asserted-by":"crossref","unstructured":"Partlov\u00e1, S. et al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology4, e965570 (2015).","DOI":"10.4161\/21624011.2014.965570"},{"key":"2851_CR389","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.chom.2025.04.022","volume":"33","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy. Cell Host Microbe33, 915\u2013931.e9 (2025).","journal-title":"Cell Host Microbe"},{"key":"2851_CR390","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1158\/1078-0432.CCR-22-1125","volume":"28","author":"A Dias Costa","year":"2022","unstructured":"Dias Costa, A. et al. Neoadjuvant chemotherapy is associated with altered immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer. Clin. Cancer Res.28, 5167\u20135179 (2022).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR391","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh4050","volume":"8","author":"T Walle","year":"2022","unstructured":"Walle, T. et al. Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8. Sci. Adv.8, eabh4050 (2022).","journal-title":"Sci. Adv."},{"key":"2851_CR392","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06377-7","volume":"23","author":"H Burckel","year":"2025","unstructured":"Burckel, H. et al. Distinct immune responses to proton and photon radiotherapy: implications for anti-PD-L1 combination therapy in colorectal cancer. J. Transl. Med.23, 360 (2025).","journal-title":"J. Transl. Med."},{"key":"2851_CR393","doi-asserted-by":"publisher","first-page":"10466","DOI":"10.7150\/thno.45211","volume":"10","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8+ T-cell memory in wild-type and humanized mice. Theranostics10, 10466\u201310482 (2020).","journal-title":"Theranostics"},{"key":"2851_CR394","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-023-00746-x","volume":"22","author":"WJ Leonard","year":"2023","unstructured":"Leonard, W. J. & Lin, J.-X. Strategies to therapeutically modulate cytokine action. Nat. Rev. Drug Discov.22, 827\u2013854 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2851_CR395","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/j.1476-5381.2011.01551.x","volume":"165","author":"DJ Scholten","year":"2012","unstructured":"Scholten, D. J. et al. Pharmacological modulation of chemokine receptor function. Br. J. Pharmacol.165, 1617\u20131643 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"2851_CR396","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.7150\/thno.15625","volume":"7","author":"H Ha","year":"2017","unstructured":"Ha, H., Debnath, B. & Neamati, N. Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases. Theranostics7, 1543\u20131588 (2017).","journal-title":"Theranostics"},{"key":"2851_CR397","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"J S","year":"2020","unstructured":"S, J. et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat. Rev. Cancer20, 485\u2013503 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR398","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier, S., Gouwy, M. & Proost, P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell. Mol. Immunol.20, 217\u2013251 (2023).","journal-title":"Cell. Mol. Immunol."},{"key":"2851_CR399","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","volume":"35","author":"W Liao","year":"2019","unstructured":"Liao, W. et al. KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer. Cancer Cell35, 559\u2013572.e7 (2019).","journal-title":"Cancer Cell"},{"key":"2851_CR400","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/molecules27010137","volume":"27","author":"Z-J Han","year":"2021","unstructured":"Han, Z.-J. et al. Roles of the CXCL8-CXCR1\/2 axis in the tumor microenvironment and immunotherapy. Molecules27, 137 (2021).","journal-title":"Molecules"},{"key":"2851_CR401","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1158\/1078-0432.CCR-19-2625","volume":"26","author":"S Greene","year":"2020","unstructured":"Greene, S. et al. Inhibition of MDSC trafficking with SX-682, a CXCR1\/2 inhibitor, enhances NK-cell immunotherapy in head and neck cancer models. Clin. Cancer Res.26, 1420\u20131431 (2020).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR402","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","volume":"32","author":"V Kumar","year":"2017","unstructured":"Kumar, V. et al. Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors. Cancer Cell32, 654\u2013668.e5 (2017).","journal-title":"Cancer Cell"},{"key":"2851_CR403","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","volume":"42","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Cancer Cell42, 885\u2013903.e4 (2024).","journal-title":"Cancer Cell"},{"key":"2851_CR404","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening, T. M. et al. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol.17, 651\u2013662 (2016).","journal-title":"Lancet Oncol."},{"key":"2851_CR405","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00280-013-2099-8","volume":"71","author":"SK Sandhu","year":"2013","unstructured":"Sandhu, S. K. et al. A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother. Pharmacol.71, 1041\u20131050 (2013).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2851_CR406","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","volume":"31","author":"KJ Pienta","year":"2013","unstructured":"Pienta, K. J. et al. Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Invest. N. Drugs31, 760\u2013768 (2013).","journal-title":"Invest. N. Drugs"},{"key":"2851_CR407","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/HYPERTENSIONAHA.112.201251","volume":"60","author":"CT Chan","year":"2012","unstructured":"Chan, C. T. et al. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone\/salt-treated mice. Hypertension60, 1207\u20131212 (2012).","journal-title":"Hypertension"},{"key":"2851_CR408","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","volume":"127","author":"S Cipriani","year":"2013","unstructured":"Cipriani, S. et al. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. Circulation127, 2114\u20132124 (2013).","journal-title":"Circulation"},{"key":"2851_CR409","doi-asserted-by":"publisher","first-page":"ofz112","DOI":"10.1093\/ofid\/ofz112","volume":"6","author":"D Francisci","year":"2019","unstructured":"Francisci, D. et al. Maraviroc intensification modulates atherosclerotic progression in hiv-suppressed patients at high cardiovascular risk. A randomized, crossover pilot study. Open Forum Infect. Dis.6, ofz112 (2019).","journal-title":"Open Forum Infect. Dis."},{"key":"2851_CR410","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn6331","volume":"10","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y. et al. MAIT cell activation and recruitment in inflammation and tissue damage in acute appendicitis. Sci. Adv.10, eadn6331 (2024).","journal-title":"Sci. Adv."},{"key":"2851_CR411","doi-asserted-by":"publisher","first-page":"e008078","DOI":"10.1136\/jitc-2023-008078","volume":"12","author":"CLC Gudd","year":"2024","unstructured":"Gudd, C. L. C. et al. Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis. J. Immunother. Cancer12, e008078 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2851_CR412","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/HEP.0000000000000439","volume":"78","author":"QM Anstee","year":"2023","unstructured":"Anstee, Q. M. et al. Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: results from the phase 2b TANDEM study. Hepatology78, 1223\u20131239 (2023).","journal-title":"Hepatology"},{"key":"2851_CR413","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310304","volume":"11","author":"X Luo","year":"2024","unstructured":"Luo, X. et al. SOX12 facilitates hepatocellular carcinoma progression and metastasis through promoting regulatory T-cells infiltration and immunosuppression. Adv. Sci.11, e2310304 (2024).","journal-title":"Adv. Sci."},{"key":"2851_CR414","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1158\/0008-5472.CAN-18-0365","volume":"78","author":"TB Shabaneh","year":"2018","unstructured":"Shabaneh, T. B. et al. Oncogenic BRAFV600E governs regulatory T-cell recruitment during melanoma tumorigenesis. Cancer Res.78, 5038\u20135049 (2018).","journal-title":"Cancer Res."},{"key":"2851_CR415","doi-asserted-by":"publisher","first-page":"e1175794","DOI":"10.1080\/2162402X.2016.1175794","volume":"5","author":"GM Wiedemann","year":"2016","unstructured":"Wiedemann, G. M. et al. Cancer cell-derived IL-1\u03b1 induces CCL22 and the recruitment of regulatory T cells. Oncoimmunology5, e1175794 (2016).","journal-title":"Oncoimmunology"},{"key":"2851_CR416","doi-asserted-by":"crossref","unstructured":"van Gulijk, M. et al. PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Sci. Immunol. 8, eabn6173 (2023).","DOI":"10.1126\/sciimmunol.abn6173"},{"key":"2851_CR417","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1158\/1078-0432.CCR-19-1090","volume":"25","author":"T Doi","year":"2019","unstructured":"Doi, T. et al. A phase I study of the anti-CC chemokine receptor 4 antibody, mogamulizumab, in combination with nivolumab in patients with advanced or metastatic solid tumors. Clin. Cancer Res.25, 6614\u20136622 (2019).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR418","doi-asserted-by":"crossref","unstructured":"Zamarin D. et al. Mogamulizumab in combination with durvalumab or tremelimumab in patients with advanced solid tumors: a phase I study. Clin. Cancer Res.26, 4531\u20134541 (2020).","DOI":"10.1158\/1078-0432.CCR-20-0328"},{"key":"2851_CR419","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1158\/1078-0432.CCR-15-0357","volume":"21","author":"K Kurose","year":"2015","unstructured":"Kurose, K. et al. Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients. Clin. Cancer Res.21, 4327\u20134336 (2015).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR420","doi-asserted-by":"publisher","first-page":"e003847","DOI":"10.1136\/jitc-2021-003847","volume":"10","author":"M Wehrli","year":"2022","unstructured":"Wehrli, M. et al. Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS). J. Immunother. Cancer10, e003847 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2851_CR421","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/ard.2010.134254","volume":"70","author":"P Quartier","year":"2011","unstructured":"Quartier, P. et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann. Rheum. Dis.70, 747\u2013754 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"2851_CR422","doi-asserted-by":"publisher","first-page":"e751","DOI":"10.1097\/CCM.0000000000001654","volume":"44","author":"G Cavalli","year":"2016","unstructured":"Cavalli, G. et al. Treating life-threatening myocarditis by blocking interleukin-1. Crit. Care Med.44, e751\u2013e754 (2016).","journal-title":"Crit. Care Med."},{"key":"2851_CR423","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19967-4","volume":"11","author":"MD Fahlberg","year":"2020","unstructured":"Fahlberg, M. D. et al. Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates. Nat. Commun.11, 6078 (2020).","journal-title":"Nat. Commun."},{"key":"2851_CR424","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","volume":"384","author":"REMAP-CAP Investigators","year":"2021","unstructured":"REMAP-CAP Investigators et al. Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N. Engl. J. Med.384, 1491\u20131502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2851_CR425","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.trecan.2022.04.001","volume":"8","author":"F M\u00e4rkl","year":"2022","unstructured":"M\u00e4rkl, F., Huynh, D., Endres, S. & Kobold, S. Utilizing chemokines in cancer immunotherapy. Trends Cancer8, 670\u2013682 (2022).","journal-title":"Trends Cancer"},{"key":"2851_CR426","doi-asserted-by":"publisher","first-page":"e1074374","DOI":"10.1080\/2162402X.2015.1074374","volume":"5","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity. Oncoimmunology5, e1074374 (2016).","journal-title":"Oncoimmunology"},{"key":"2851_CR427","doi-asserted-by":"publisher","first-page":"679","DOI":"10.15252\/emmm.201506145","volume":"8","author":"J Decalf","year":"2016","unstructured":"Decalf, J. et al. Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies. EMBO Mol. Med.8, 679\u2013683 (2016).","journal-title":"EMBO Mol. Med."},{"key":"2851_CR428","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ni.3201","volume":"16","author":"R Barreira da Silva","year":"2015","unstructured":"Barreira da Silva, R. et al. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat. Immunol.16, 850\u2013858 (2015).","journal-title":"Nat. Immunol."},{"key":"2851_CR429","doi-asserted-by":"publisher","first-page":"e005026","DOI":"10.1136\/jitc-2022-005026","volume":"10","author":"R Raja","year":"2022","unstructured":"Raja, R. et al. PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling. J. Immunother. Cancer10, e005026 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"2851_CR430","doi-asserted-by":"crossref","unstructured":"Ky, T. et al. Off-the-shelf prostate stem cell antigen-directed chimeric antigen receptor natural killer cell therapy to treat pancreatic cancer. Gastroenterology162, 1319\u20131333 (2022).","DOI":"10.1053\/j.gastro.2021.12.281"},{"key":"2851_CR431","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1200\/JCO.23.02019","volume":"42","author":"FY Lin","year":"2024","unstructured":"Lin, F. Y. et al. Phase I trial of GD2.CART cells augmented with constitutive interleukin-7 receptor for treatment of high-grade pediatric CNS tumors. J. Clin. Oncol.42, 2769\u20132779 (2024).","journal-title":"J. Clin. Oncol."},{"key":"2851_CR432","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13045-021-01128-9","volume":"14","author":"N Pang","year":"2021","unstructured":"Pang, N. et al. IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin. J. Hematol. Oncol. J. Hematol. Oncol.14, 118 (2021).","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"2851_CR433","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","volume":"30","author":"D Marin","year":"2024","unstructured":"Marin, D. et al. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial. Nat. Med.30, 772\u2013784 (2024).","journal-title":"Nat. Med."},{"key":"2851_CR434","first-page":"1973","volume":"6","author":"M Yang","year":"2021","unstructured":"Yang, M., Li, J., Gu, P. & Fan, X. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioact. Mater.6, 1973\u20131987 (2021).","journal-title":"Bioact. Mater."},{"key":"2851_CR435","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202402580","volume":"36","author":"W Yang","year":"2024","unstructured":"Yang, W. et al. Immunogenic material vaccine for cancer immunotherapy by structure-dependent immune cell trafficking and modulation. Adv. Mater.36, e2402580 (2024).","journal-title":"Adv. Mater."},{"key":"2851_CR436","doi-asserted-by":"publisher","first-page":"eaax4690","DOI":"10.1126\/sciadv.aax4690","volume":"6","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci. Adv.6, eaax4690 (2020).","journal-title":"Sci. Adv."},{"key":"2851_CR437","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41551-020-00644-2","volume":"5","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases. Nat. Biomed. Eng.5, 441\u2013454 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"2851_CR438","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/1535-7163.MCT-10-0717","volume":"10","author":"H Yao","year":"2011","unstructured":"Yao, H. et al. Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle. Mol. Cancer Ther.10, 1082\u20131092 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"2851_CR439","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1200\/JCO.1991.9.4.694","volume":"9","author":"JP Siegel","year":"1991","unstructured":"Siegel, J. P. & Puri, R. K. Interleukin-2 toxicity. J. Clin. Oncol.9, 694\u2013704 (1991).","journal-title":"J. Clin. Oncol."},{"key":"2851_CR440","doi-asserted-by":"publisher","first-page":"17554","DOI":"10.1021\/acsnano.3c06733","volume":"17","author":"H Shin","year":"2023","unstructured":"Shin, H., Kang, S., Won, C. & Min, D.-H. Enhanced local delivery of engineered IL-2 mRNA by porous silica nanoparticles to promote effective antitumor immunity. ACS Nano17, 17554\u201317567 (2023).","journal-title":"ACS Nano"},{"key":"2851_CR441","doi-asserted-by":"crossref","unstructured":"Xu, S. et al. Tumor-tailored ionizable lipid nanoparticles facilitate IL-12 circular RNA delivery for enhanced lung cancer immunotherapy. Adv. Mater.36, 2400307 (2024).","DOI":"10.1002\/adma.202400307"},{"key":"2851_CR442","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","volume":"22","author":"R Hernandez","year":"2022","unstructured":"Hernandez, R., P\u00f5der, J., LaPorte, K. M. & Malek, T. R. Engineering IL-2 for immunotherapy of autoimmunity and cancer. Nat. Rev. Immunol.22, 614\u2013628 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2851_CR443","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1200\/JCO.1995.13.3.688","volume":"13","author":"G Fyfe","year":"1995","unstructured":"Fyfe, G. et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J. Clin. Oncol.13, 688\u2013696 (1995).","journal-title":"J. Clin. Oncol."},{"key":"2851_CR444","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","volume":"79","author":"J He","year":"2020","unstructured":"He, J. et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann. Rheum. Dis.79, 141\u2013149 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"2851_CR445","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abc0653","volume":"13","author":"C Gorby","year":"2020","unstructured":"Gorby, C. et al. Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. Sci. Signal.13, eabc0653 (2020).","journal-title":"Sci. Signal."},{"key":"2851_CR446","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41551-020-00627-3","volume":"5","author":"A Ishihara","year":"2021","unstructured":"Ishihara, A. et al. Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nat. Biomed. Eng.5, 387\u2013398 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"2851_CR447","doi-asserted-by":"publisher","first-page":"632364","DOI":"10.3389\/fonc.2021.632364","volume":"11","author":"T Qiao","year":"2021","unstructured":"Qiao, T. et al. Inhibition of LDH-A by oxamate enhances the efficacy of anti-PD-1 treatment in an NSCLC humanized mouse model. Front. Oncol.11, 632364 (2021).","journal-title":"Front. Oncol."},{"key":"2851_CR448","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41416-019-0717-x","volume":"122","author":"M Beloueche-Babari","year":"2020","unstructured":"Beloueche-Babari, M. et al. Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration. Br. J. Cancer122, 895\u2013903 (2020).","journal-title":"Br. J. Cancer"},{"key":"2851_CR449","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.7150\/thno.20270","volume":"7","author":"C Li","year":"2017","unstructured":"Li, C. et al. Dioscin exerts protective effects against crystalline silica-induced pulmonary fibrosis in mice. Theranostics7, 4255\u20134275 (2017).","journal-title":"Theranostics"},{"key":"2851_CR450","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/JCI76012","volume":"125","author":"VA Gerriets","year":"2015","unstructured":"Gerriets, V. A. et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest.125, 194\u2013207 (2015).","journal-title":"J. Clin. Invest."},{"key":"2851_CR451","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41420-024-01807-9","volume":"10","author":"S Zhang","year":"2024","unstructured":"Zhang, S., Lv, K., Liu, Z., Zhao, R. & Li, F. Fatty acid metabolism of immune cells: a new target of tumour immunotherapy. Cell Death Discov.10, 39 (2024).","journal-title":"Cell Death Discov."},{"key":"2851_CR452","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","volume":"32","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell32, 377\u2013391.e9 (2017).","journal-title":"Cancer Cell"},{"key":"2851_CR453","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metab.33, 1001\u20131012.e5 (2021).","journal-title":"Cell Metab."},{"key":"2851_CR454","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity54, 1561\u20131577.e7 (2021).","journal-title":"Immunity"},{"key":"2851_CR455","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1053\/j.gastro.2007.03.113","volume":"133","author":"JW Lee","year":"2007","unstructured":"Lee, J. W. et al. Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology133, 108\u2013123 (2007).","journal-title":"Gastroenterology"},{"key":"2851_CR456","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/2159-8290.CD-21-0030","volume":"12","author":"C Vernieri","year":"2022","unstructured":"Vernieri, C. et al. Fasting-mimicking diet is safe and reshapes metabolism and antitumor immunity in patients with cancer. Cancer Discov.12, 90\u2013107 (2022).","journal-title":"Cancer Discov."},{"key":"2851_CR457","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cmet.2024.11.004","volume":"37","author":"F Ligorio","year":"2025","unstructured":"Ligorio, F. et al. Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients. Cell Metab.37, 330\u2013344.e7 (2025).","journal-title":"Cell Metab."},{"key":"2851_CR458","doi-asserted-by":"publisher","first-page":"105744","DOI":"10.1016\/j.msard.2024.105744","volume":"88","author":"L Lorefice","year":"2024","unstructured":"Lorefice, L., Pitzalis, M. & Zoledziewska, M. Intermittent and periodic fasting\u2014evidence and perspectives in multiple sclerosis. Mult. Scler. Relat. Disord.88, 105744 (2024).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"2851_CR459","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jnutbio.2014.07.006","volume":"25","author":"M\u00c1 Rosillo","year":"2014","unstructured":"Rosillo, M. \u00c1 et al. Anti-inflammatory and joint protective effects of extra-virgin olive-oil polyphenol extract in experimental arthritis. J. Nutr. Biochem.25, 1275\u20131281 (2014).","journal-title":"J. Nutr. Biochem."},{"key":"2851_CR460","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1158\/1078-0432.CCR-18-0980","volume":"24","author":"A Orillion","year":"2018","unstructured":"Orillion, A. et al. Dietary protein restriction reprograms tumor-associated macrophages and enhances immunotherapy. Clin. Cancer Res.24, 6383\u20136395 (2018).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR461","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cmet.2018.02.009","volume":"27","author":"C Rubio-Pati\u00f1o","year":"2018","unstructured":"Rubio-Pati\u00f1o, C. et al. Low-protein diet induces IRE1\u03b1-dependent anticancer immunosurveillance. Cell Metab.27, 828\u2013842.e7 (2018).","journal-title":"Cell Metab."},{"key":"2851_CR462","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2014.05.012","volume":"157","author":"YS Lee","year":"2014","unstructured":"Lee, Y. S. et al. Increased adipocyte O2 consumption triggers HIF-1\u03b1, causing inflammation and insulin resistance in obesity. Cell157, 1339\u20131352 (2014).","journal-title":"Cell"},{"key":"2851_CR463","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32348-3","volume":"13","author":"S Cao","year":"2022","unstructured":"Cao, S. et al. EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance. Nat. Commun.13, 4684 (2022).","journal-title":"Nat. Commun."},{"key":"2851_CR464","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature11868","volume":"496","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld, M. et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature496, 518\u2013522 (2013).","journal-title":"Nature"},{"key":"2851_CR465","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15524-1","volume":"11","author":"W He","year":"2020","unstructured":"He, W. et al. High-salt diet inhibits tumour growth in mice via regulating myeloid-derived suppressor cell differentiation. Nat. Commun.11, 1732 (2020).","journal-title":"Nat. Commun."},{"key":"2851_CR466","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman, C., Petitprez, F., Calderaro, J. & Fridman, W. H. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat. Rev. Cancer19, 307\u2013325 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"2851_CR467","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ni.3836","volume":"18","author":"A Johansson-Percival","year":"2017","unstructured":"Johansson-Percival, A. et al. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat. Immunol.18, 1207\u20131217 (2017).","journal-title":"Nat. Immunol."},{"key":"2851_CR468","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1158\/1078-0432.CCR-24-1594","volume":"31","author":"T Lanickova","year":"2025","unstructured":"Lanickova, T. et al. Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancer. Clin. Cancer Res.31, 164\u2013180 (2025).","journal-title":"Clin. Cancer Res."},{"key":"2851_CR469","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ccell.2023.02.002","volume":"41","author":"G Vella","year":"2023","unstructured":"Vella, G., Hua, Y. & Bergers, G. High endothelial venules in cancer: regulation, function, and therapeutic implication. Cancer Cell41, 527\u2013545 (2023).","journal-title":"Cancer Cell"},{"key":"2851_CR470","doi-asserted-by":"publisher","first-page":"736670","DOI":"10.3389\/fimmu.2021.736670","volume":"12","author":"G Vella","year":"2021","unstructured":"Vella, G., Guelfi, S. & Bergers, G. High endothelial venules: a vascular perspective on tertiary lymphoid structures in cancer. Front. Immunol.12, 736670 (2021).","journal-title":"Front. Immunol."},{"key":"2851_CR471","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev.immunol.21.090501.080131","volume":"22","author":"SD Rosen","year":"2004","unstructured":"Rosen, S. D. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol.22, 129\u2013156 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"2851_CR472","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-11-0431","volume":"71","author":"L Martinet","year":"2011","unstructured":"Martinet, L. et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res.71, 5678\u20135687 (2011).","journal-title":"Cancer Res."},{"key":"2851_CR473","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.immuni.2005.10.002","volume":"23","author":"JL Browning","year":"2005","unstructured":"Browning, J. L. et al. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity23, 539\u2013550 (2005).","journal-title":"Immunity"},{"key":"2851_CR474","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9679","volume":"9","author":"E Allen","year":"2017","unstructured":"Allen, E. et al. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci. Transl. Med.9, eaak9679 (2017).","journal-title":"Sci. Transl. Med."},{"key":"2851_CR475","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","volume":"40","author":"A Asrir","year":"2022","unstructured":"Asrir, A. et al. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell40, 318\u2013334.e9 (2022).","journal-title":"Cancer Cell"},{"key":"2851_CR476","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb6731","volume":"13","author":"AU Kabir","year":"2021","unstructured":"Kabir, A. U. et al. Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity. Sci. Transl. Med.13, eabb6731 (2021).","journal-title":"Sci. Transl. Med."},{"key":"2851_CR477","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-023-00706-z","volume":"19","author":"Y Sato","year":"2023","unstructured":"Sato, Y. et al. The roles of tertiary lymphoid structures in chronic diseases. Nat. Rev. Nephrol.19, 525\u2013537 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"2851_CR478","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101050RR","volume":"35","author":"M Zhu","year":"2021","unstructured":"Zhu, M. et al. Cardiac ectopic lymphoid follicle formation in viral myocarditis involving the regulation of podoplanin in Th17 cell differentiation. FASEB J.35, e21975 (2021).","journal-title":"FASEB J."},{"key":"2851_CR479","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/art.41289","volume":"72","author":"D Lucchesi","year":"2020","unstructured":"Lucchesi, D. et al. Impaired interleukin-27-mediated control of CD4+ T cell function impact on ectopic lymphoid structure formation in patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. Hoboken NJ72, 1559\u20131570 (2020).","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"2851_CR480","doi-asserted-by":"publisher","first-page":"e139905","DOI":"10.1172\/JCI139905","volume":"131","author":"G No\u00ebl","year":"2021","unstructured":"No\u00ebl, G. et al. Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity. J. Clin. Invest131, e139905 (2021).","journal-title":"J. Clin. Invest"},{"key":"2851_CR481","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.3390\/ijms241612535","volume":"24","author":"R Luo","year":"2023","unstructured":"Luo, R. et al. T follicular helper cells in tertiary lymphoid structure contribute to renal fibrosis by IL-21. Int. J. Mol. Sci.24, 12535 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2851_CR482","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J. Hematol. Oncol. J. Hematol. Oncol.15, 34 (2022).","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"2851_CR483","doi-asserted-by":"crossref","unstructured":"Ma, K. et al. The good and the bad collagens of fibrosis\u2014their role in signaling and organ function. Adv. Drug Deliv. Rev. 121, 43\u201356 (2017).","DOI":"10.1016\/j.addr.2017.07.014"},{"key":"2851_CR484","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/0008-5472.CAN-14-1027","volume":"75","author":"J Zhu","year":"2015","unstructured":"Zhu, J. et al. Chaperone Hsp47 drives malignant growth and invasion by modulating an ECM gene network. Cancer Res.75, 1580\u20131591 (2015).","journal-title":"Cancer Res."},{"key":"2851_CR485","doi-asserted-by":"crossref","unstructured":"Ishikawa, Y., Rubin, K., B\u00e4chinger, H. P. & Kalamajski, S. The endoplasmic reticulum-resident collagen chaperone Hsp47 interacts with and promotes the secretion of decorin, fibromodulin, and lumican. J. Biol. Chem. 293, 13707\u201313716 (2018).","DOI":"10.1074\/jbc.RA117.000758"},{"key":"2851_CR486","doi-asserted-by":"crossref","unstructured":"Wang L. et al. Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity. Cell Rep. Med. 5, 101533 (2024).","DOI":"10.1016\/j.xcrm.2024.101533"},{"key":"2851_CR487","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/onc.2012.202","volume":"32","author":"A-M Baker","year":"2013","unstructured":"Baker, A.-M., Bird, D., Lang, G., Cox, T. R. & Erler, J. T. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene32, 1863\u20131868 (2013).","journal-title":"Oncogene"},{"key":"2851_CR488","doi-asserted-by":"crossref","unstructured":"Maller, O. et al. Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression. Nat. Mater. 20, 548\u2013559 (2021).","DOI":"10.1038\/s41563-020-00849-5"},{"key":"2851_CR489","unstructured":"Chitty, J. L. et al. A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Nat. Cancer4, 1326\u20131344 (2023)."},{"key":"2851_CR490","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1182\/blood-2024-204290","volume":"144","author":"P Tan","year":"2024","unstructured":"Tan, P. et al. Multicenter, open-label phase 1\/2a study of Pxs-5505 and ruxolitinib in patients with primary, post-polycythemia vera (PV) or post-essential thrombocythemia (ET) myelofibrosis. Blood144, 1001 (2024).","journal-title":"Blood"},{"key":"2851_CR491","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1021\/acs.jmedchem.9b00335","volume":"62","author":"L Leung","year":"2019","unstructured":"Leung, L. et al. Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): design and structure\u2013activity relationships. J. Med. Chem.62, 5863\u20135884 (2019).","journal-title":"J. Med. Chem."},{"key":"2851_CR492","doi-asserted-by":"crossref","unstructured":"Benson, A. B. et al. A phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma. Oncologist22, 241-e15 (2017).","DOI":"10.1634\/theoncologist.2017-0024"},{"key":"2851_CR493","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","volume":"10","author":"Y Kieffer","year":"2020","unstructured":"Kieffer, Y. et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov.10, 1330\u20131351 (2020).","journal-title":"Cancer Discov."},{"key":"2851_CR494","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol. Cancer22, 159 (2023).","journal-title":"Mol. Cancer"},{"key":"2851_CR495","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40850-5","volume":"14","author":"Z Xiao","year":"2023","unstructured":"Xiao, Z. et al. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat. Commun.14, 5110 (2023).","journal-title":"Nat. Commun."},{"key":"2851_CR496","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.annonc.2020.10.474","volume":"32","author":"S Hiltbrunner","year":"2021","unstructured":"Hiltbrunner, S. et al. Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial. Ann. Oncol.32, 120\u2013121 (2021).","journal-title":"Ann. Oncol."},{"key":"2851_CR497","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/1535-7163.MCT-22-0313","volume":"22","author":"T Kato","year":"2023","unstructured":"Kato, T. et al. Near-infrared photoimmunotherapy targeting podoplanin-expressing cancer cells and cancer-associated fibroblasts. Mol. Cancer Ther.22, 75\u201388 (2023).","journal-title":"Mol. Cancer Ther."},{"key":"2851_CR498","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o, J. L. et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature611, 810\u2013817 (2022).","journal-title":"Nature"},{"key":"2851_CR499","doi-asserted-by":"crossref","unstructured":"Parhi, L. et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat. Commun. 11, 3259 (2020).","DOI":"10.1038\/s41467-020-16967-2"},{"key":"2851_CR500","doi-asserted-by":"crossref","unstructured":"Kabwe, M, Dashper, S, Bachrach, G, & Tucci, J. Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response? FEMS Microbiol. Rev. 45, fuab017 (2021).","DOI":"10.1093\/femsre\/fuab017"},{"key":"2851_CR501","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1053\/j.gastro.2018.12.003","volume":"156","author":"D Triner","year":"2019","unstructured":"Triner, D. et al. Neutrophils restrict tumor-associated microbiota to reduce growth and invasion of colon tumors in mice. Gastroenterology156, 1467\u20131482 (2019).","journal-title":"Gastroenterology"},{"key":"2851_CR502","doi-asserted-by":"crossref","unstructured":"Zheng, J. H. et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci. Transl. Med. 9, eaak9537 (2017).","DOI":"10.1126\/scitranslmed.aak9537"},{"key":"2851_CR503","doi-asserted-by":"crossref","unstructured":"Canale, F. P. et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature598, 662\u2013666 (2021).","DOI":"10.1038\/s41586-021-04003-2"},{"key":"2851_CR504","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205563","volume":"10","author":"R Qu","year":"2023","unstructured":"Qu, R. et al. Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer. Adv. Sci.10, e2205563 (2023).","journal-title":"Adv. Sci."},{"key":"2851_CR505","doi-asserted-by":"publisher","first-page":"2186114","DOI":"10.1080\/19490976.2023.2186114","volume":"15","author":"H Xu","year":"2023","unstructured":"Xu, H., Luo, H., Zhang, J., Li, K. & Lee, M.-H. Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer. Gut Microbes15, 2186114 (2023).","journal-title":"Gut Microbes"},{"key":"2851_CR506","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41586-025-09249-8","volume":"644","author":"L Ny","year":"2025","unstructured":"Ny, L. et al. Microbiota-driven antitumour immunity mediated by dendritic cell migration. Nature644, 1058\u20131068 (2025).","journal-title":"Nature"},{"key":"2851_CR507","doi-asserted-by":"crossref","unstructured":"Sn, C. et al. CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome. J. Transl. Autoimmun. 3, 100032 (2019).","DOI":"10.1016\/j.jtauto.2019.100032"},{"key":"2851_CR508","doi-asserted-by":"crossref","unstructured":"Prado, C. et al. GPR43 stimulation on TCR\u03b1\u03b2+ intraepithelial colonic lymphocytes inhibits the recruitment of encephalitogenic T-cells into the central nervous system and attenuates the development of autoimmunity. J. Neuroinflammation20, 135 (2023).","DOI":"10.1186\/s12974-023-02815-9"},{"key":"2851_CR509","doi-asserted-by":"crossref","unstructured":"Duscha, A. et al. Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell180, 1067\u20131080 (2020).","DOI":"10.1016\/j.cell.2020.02.035"},{"key":"2851_CR510","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/ni.3713","volume":"18","author":"E Mari\u00f1o","year":"2017","unstructured":"Mari\u00f1o, E. et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat. Immunol.18, 552\u2013562 (2017).","journal-title":"Nat. Immunol."},{"key":"2851_CR511","unstructured":"Riquelme, E. et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell178, 795\u2013806 (2019)."},{"key":"2851_CR512","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch, E. N. et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science371, 602\u2013609 (2021).","journal-title":"Science"},{"key":"2851_CR513","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar, D. et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science371, 595\u2013602 (2021).","journal-title":"Science"},{"key":"2851_CR514","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409837","volume":"12","author":"L Gao","year":"2025","unstructured":"Gao, L. et al. Microbiota-derived inosine suppresses systemic autoimmunity via restriction of B cell differentiation and migration. Adv. Sci.12, e2409837 (2025).","journal-title":"Adv. Sci."},{"key":"2851_CR515","doi-asserted-by":"crossref","unstructured":"de Groot, P. et al. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut70, 92\u2013105 (2021).","DOI":"10.1136\/gutjnl-2020-322630"},{"key":"2851_CR516","doi-asserted-by":"publisher","first-page":"118231","DOI":"10.1016\/j.carbpol.2021.118231","volume":"267","author":"C Guo","year":"2021","unstructured":"Guo, C. et al. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon. Carbohydr. Polym.267, 118231 (2021).","journal-title":"Carbohydr. Polym."},{"key":"2851_CR517","doi-asserted-by":"crossref","unstructured":"Li, N. et al. Prebiotic inulin controls Th17 cells mediated central nervous system autoimmunity through modulating the gut microbiota and short chain fatty acids. Gut Microbes16, 2402547 (2024).","DOI":"10.1080\/19490976.2024.2402547"},{"key":"2851_CR518","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto, F., Lenig, D., F\u00f6rster, R., Lipp, M. & Lanzavecchia, A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature401, 708\u2013712 (1999).","journal-title":"Nature"},{"key":"2851_CR519","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander, R. et al. CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer. Immunity51, 1028\u20131042.e4 (2019).","journal-title":"Immunity"},{"key":"2851_CR520","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.immuni.2024.02.007","volume":"57","author":"A Franken","year":"2024","unstructured":"Franken, A. et al. CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy. Immunity57, 541\u2013558.e7 (2024).","journal-title":"Immunity"},{"key":"2851_CR521","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01867-9","volume":"8","author":"SR Bailey","year":"2017","unstructured":"Bailey, S. R. et al. Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence. Nat. Commun.8, 1961 (2017).","journal-title":"Nat. Commun."},{"key":"2851_CR522","doi-asserted-by":"crossref","unstructured":"Fu, C. et al. JMJD3 regulates CD4 T cell trafficking by targeting actin cytoskeleton regulatory gene Pdlim4. J. Clin. Investig. 129, 4745\u20134757 (2019).","DOI":"10.1172\/JCI128293"},{"key":"2851_CR523","doi-asserted-by":"crossref","unstructured":"Ma, M. A. et al. CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity. Immunity56, 1613\u20131630 (2023).","DOI":"10.1016\/j.immuni.2023.06.003"},{"key":"2851_CR524","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2020.02.015","volume":"180","author":"Y Lu","year":"2020","unstructured":"Lu, Y. et al. Complement signals determine opposite effects of B cells in chemotherapy-induced immunity. Cell180, 1081\u20131097.e24 (2020).","journal-title":"Cell"},{"key":"2851_CR525","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.immuni.2022.02.009","volume":"55","author":"X Hu","year":"2022","unstructured":"Hu, X. & Liu, X. S. A high-resolution view of intra-tumoral B cell immunity. Immunity55, 387\u2013389 (2022).","journal-title":"Immunity"},{"key":"2851_CR526","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.immuni.2022.04.016","volume":"55","author":"BW MacNabb","year":"2022","unstructured":"MacNabb, B. W. et al. Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing. Immunity55, 982\u2013997.e8 (2022).","journal-title":"Immunity"},{"key":"2851_CR527","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.immuni.2013.04.011","volume":"38","author":"A Schlitzer","year":"2013","unstructured":"Schlitzer, A. et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity38, 970\u2013983 (2013).","journal-title":"Immunity"},{"key":"2851_CR528","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.immuni.2017.01.003","volume":"46","author":"A Brewitz","year":"2017","unstructured":"Brewitz, A. et al. CD8+ T cells orchestrate pDC-XCR1+ dendritic cell spatial and functional cooperativity to optimize priming. Immunity46, 205\u2013219 (2017).","journal-title":"Immunity"},{"key":"2851_CR529","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.immuni.2020.04.005","volume":"52","author":"C Bosteels","year":"2020","unstructured":"Bosteels, C. et al. Inflammatory type 2 cDCs acquire features of cDC1s and macrophages to orchestrate immunity to respiratory virus infection. Immunity52, 1039\u20131056.e9 (2020).","journal-title":"Immunity"},{"key":"2851_CR530","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.7150\/thno.32543","volume":"9","author":"E-B Chen","year":"2019","unstructured":"Chen, E.-B. et al. The miR-561-5p\/CX3CL1 signaling axis regulates pulmonary metastasis in hepatocellular carcinoma involving CX3CR1+ natural killer cells infiltration. Theranostics9, 4779\u20134794 (2019).","journal-title":"Theranostics"},{"key":"2851_CR531","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jcyt.2016.08.006","volume":"18","author":"MS Yoon","year":"2016","unstructured":"Yoon, M. S. et al. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor. Cytotherapy18, 1532\u20131542 (2016).","journal-title":"Cytotherapy"},{"key":"2851_CR532","doi-asserted-by":"publisher","first-page":"e002837","DOI":"10.1136\/jitc-2021-002837","volume":"9","author":"AA Fitzgerald","year":"2021","unstructured":"Fitzgerald, A. A. et al. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. J. Immunother. Cancer9, e002837 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2851_CR533","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.molimm.2021.03.003","volume":"136","author":"S Rezaeifard","year":"2021","unstructured":"Rezaeifard, S., Talei, A., Shariat, M. & Erfani, N. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer. Mol. Immunol.136, 161\u2013167 (2021).","journal-title":"Mol. Immunol."},{"key":"2851_CR534","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133103","volume":"4","author":"LF de Andrade","year":"2019","unstructured":"de Andrade, L. F. et al. Discovery of specialized NK cell populations infiltrating human melanoma metastases. JCI Insight4, e133103 (2019).","journal-title":"JCI Insight"},{"key":"2851_CR535","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41590-024-01884-z","volume":"25","author":"H Netskar","year":"2024","unstructured":"Netskar, H. et al. Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping. Nat. Immunol.25, 1445\u20131459 (2024).","journal-title":"Nat. Immunol."},{"key":"2851_CR536","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41590-021-00943-z","volume":"22","author":"N Jacquelot","year":"2021","unstructured":"Jacquelot, N. et al. Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma. Nat. Immunol.22, 851\u2013864 (2021).","journal-title":"Nat. Immunol."},{"key":"2851_CR537","doi-asserted-by":"crossref","unstructured":"Moral J. A. et al. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity. Nature 579, 130-135 (2020).","DOI":"10.1038\/s41586-020-2015-4"},{"key":"2851_CR538","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","volume":"40","author":"A Alam","year":"2022","unstructured":"Alam, A. et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell40, 153\u2013167.e11 (2022).","journal-title":"Cancer Cell"},{"key":"2851_CR539","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","volume":"70","author":"K Movahedi","year":"2010","unstructured":"Movahedi, K. et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res70, 5728\u20135739 (2010).","journal-title":"Cancer Res"},{"key":"2851_CR540","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1016\/j.ymthe.2021.05.014","volume":"29","author":"G Bertolini","year":"2021","unstructured":"Bertolini, G. et al. A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer. Mol. Ther. J. Am. Soc. Gene Ther.29, 2963\u20132978 (2021).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"2851_CR541","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ncb3090","volume":"17","author":"W Zhou","year":"2015","unstructured":"Zhou, W. et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat. Cell Biol.17, 170\u2013182 (2015).","journal-title":"Nat. Cell Biol."},{"key":"2851_CR542","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53659-7","volume":"15","author":"H-Y Huang","year":"2024","unstructured":"Huang, H.-Y. et al. Alternations in inflammatory macrophage niche drive phenotypic and functional plasticity of Kupffer cells. Nat. Commun.15, 9337 (2024).","journal-title":"Nat. Commun."},{"key":"2851_CR543","doi-asserted-by":"crossref","unstructured":"Long, L. et al. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery. J. Exp. Clin. Cancer Res.42, 117 (2023).","DOI":"10.1186\/s13046-023-02688-z"},{"key":"2851_CR544","doi-asserted-by":"crossref","unstructured":"Pang, L. et al. Postoperative plasmacytoid dendritic cells secrete IFN\u03b1 to promote recruitment of myeloid-derived suppressor cells and drive hepatocellular carcinoma recurrence. Cancer Res. 82, 4206\u20134218 (2022).","DOI":"10.1158\/0008-5472.CAN-22-1199"},{"key":"2851_CR545","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/j.gastro.2024.02.046","volume":"167","author":"Y Xie","year":"2024","unstructured":"Xie, Y. et al. Targeting ESE3\/EHF with nifurtimox inhibits CXCR2+ neutrophil infiltration and overcomes pancreatic cancer resistance to chemotherapy and immunotherapy. Gastroenterology167, 281\u2013297 (2024).","journal-title":"Gastroenterology"},{"key":"2851_CR546","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","volume":"39","author":"Y Xiao","year":"2021","unstructured":"Xiao, Y. et al. Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. Cancer Cell39, 423\u2013437.e7 (2021).","journal-title":"Cancer Cell"},{"key":"2851_CR547","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1136\/gutjnl-2021-325272","volume":"71","author":"G Bellomo","year":"2022","unstructured":"Bellomo, G. et al. Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6\/AXL signalling axis. Gut71, 2284\u20132299 (2022).","journal-title":"Gut"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02851-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02851-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02851-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:01:50Z","timestamp":1785888110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02851-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":547,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2851"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02851-w","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"311"}}